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The varying risk factor profiles among subtypes and unique challenges observed in 
the development and course of head and neck squamous cell carcinoma (HNSCC) may 
influence patients’ diet quality and ability to eat. Patients’ dietary choices and nutritional 
status likely have consequences for disease prognosis but have not been evaluated with 
sufficient rigor. The molecular mechanisms by which diet potentially exerts its effects in 
HNSCC progression and prognosis also have not been thoroughly investigated. This research 
was conducted in the context of the University of Michigan Head and Neck Specialized 
Program of Research Excellence (HN-SPORE). Longitudinal data, including epidemiologic, 
clinical, and molecular characterization were collected from subjects enrolled into the HN-
SPORE between 2002 – 2012. Data were collected at baseline and yearly, with a mean 
follow-up time among study participants of 4.5 years. Pretreatment dietary data were 
collected from subjects using the semi-quantitative Harvard food frequency questionnaire 
(FFQ). 
The first objective of this dissertation was to identify major dietary consumption 
patterns in a population of incident cases of HNSCC, and to examine the association of these 
dietary patterns and weight status with recurrence and survival. Dietary patterns were 
identified using principal components analysis and Cox proportional hazard models were fit 
to examine these associations. Two dietary patterns were identified: a “whole foods pattern”, 
characterized by high intakes of vegetables, fruits, fish, poultry and whole grains, and a 
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“Western pattern”, characterized by high intakes of red and processed meats, refined grains, 
potatoes and French fries. In multivariable analyses, significantly fewer deaths were 
observed in subjects most adherent to the whole foods pattern (HR 0.56, 95% CI 0.34 – 0.92, 
Ptrend=0.01). Subjects classified as overweight or obese had significantly fewer deaths (HR 
0.65, 95% CI 0.49 – 0.85, P=0.001) and recurrences (HR 0.70, 95% CI 0.52 – 0.95, P=0.02) 
than normal or underweight subjects.  
The second aim of this study sought to compare pretreatment dietary intake of 
vitamins and minerals between newly diagnosed HNSCC patients with HPV-positive tumors 
to those with HPV-negative tumors. Multivariable logistic regression was used examine the 
association between reported intake of twelve micronutrients with HPV-positive tumor 
status. After controlling for potential confounding factors, significant and positive 
associations were observed between vitamin A, vitamin E, iron, β-carotene and folate intake 
and HPV-positive status (Ptrend<0.05).  
Lastly, associations between pretreatment dietary patterns, FFQ reported and serum 
levels of carotenoids and vitamin E, and presence of cachexia with pretreatment serum 
proinflammatory cytokine levels were examined. In multivariable analyses, higher whole 
foods dietary pattern scores were significantly associated with lower levels of IL-6, TNF-α, 
and IFN-γ (P = <0.001, P = 0.008, and P = 0.03, respectively). Significant downward trends 
in IL-6, TNF-α, and IFN-γ levels were found across increasing quartiles of total reported 
carotenoid intake (P = 0.006, P = 0.04, and P = 0.04, respectively).  No significant 
association was reported for the relationships between IL-6 and TNF-α levels and serum 
carotenoids. There was a significant trend towards decreased IFN-γ levels across increasing 
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quartiles of serum α-tocopherol levels (P = 0.03). No significant association was observed 
between cytokine levels and cachexia.  
In summary, consuming a pretreatment diet rich in vegetables, fruit, fish, poultry and 
whole grains were associated with lower HNSCC mortality. The reduction of 
proinflammatory cytokine levels is one potential mechanism underlying this association. The 
reported differences in micronutrient intake by HNSCC subtype provides support for the 
hypothesis that differences in lifestyle factors may contribute to the discrepancy in survival 
rates observed between HPV-positive and HPV-negative HNSCC cases. This research 
provides a basis for translational studies aimed at developing individualized dietary 










Despite advances in our understanding of the biology of head and neck squamous cell 
carcinoma (HNSCC), the 5-year survival rate of HNSCC has remained low over the past few 
decades at approximately 60% or less. These high rates are likely attributable to late 
detection and high rates of persistent and recurrent disease (1, 2). Few studies to date have 
focused on the impact of modifiable lifestyle factors, such as diet, on survival from HNSCC. 
Modifiable risk factors may serve as feasible, low-risk targets for intervention to improve 
HNSCC prognosis. To address this gap in our knowledge, the theme of this dissertation is the 
potential impact of diet and nutritional status on HNSCC pathogenesis and prognosis.  
The varying risk factor profiles and unique challenges observed in the development 
and course of HNSCC may influence patients’ dietary intake and ability to eat. Patients’ 
dietary choices and level of nutritional status likely have consequences for disease prognosis 
but these have not been comprehensively evaluated in a meaningful way. The molecular 
mechanisms by which dietary compounds potentially exert effects on HNSCC progression 
and prognosis have also not been thoroughly investigated. My dissertation research addresses 
important knowledge gaps in these areas, setting the ground for translational research aimed 
at developing individualized dietary interventions and therapeutic regimens to improve 
HNSCC recurrence and mortality rates. My dissertation work has used data collected as a 
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part of the University of Michigan Head and Neck Specialized Program of Research 
Excellence (UM HN-SPORE), one of only five such programs in the United States funded by 
the National Cancer Institute (NCI) (2P50 CA097248, Dr. Gregory Wolf, P.I.). The goal of 
the UM HN-SPORE is to translate research into clinical practice and improve the diagnosis, 
treatment and prevention of HNSCC; thus findings from my dissertation research can be 
easily integrated into interdisciplinary patient care.  




Although often combined, HNSCC is a heterogeneous disease that includes tumors of 
squamous cell histologic type arising in the oral cavity, oropharynx, nasopharynx, 
hypopharynx and larynx (Figure 1.1). HNSCC is the eigth most common type of cancer in 
the U.S. and accounts for approximately 5% of annual new cancer diagnoses worldwide (3). 
According to the NCI’s Surveillance Epidemiology and End Results (SEER) database, 
approximately 52,610 American citizens were diagnosed with the disease in 2012, of which 
70% were male. The 5-year HNSCC survival rate has remained steady since the mid-1970s 
at about 60% (Figure 1.2) (http://www.seer.cancer.gov). An estimated 50% of HNSCC 
patients experience a disease recurrence within the first two years after diagnosis (2). 
Tobacco Use and Alcohol Consumption 
 
Historically, chronic lifetime exposure to tobacco and alcohol has been accepted as 
the primary factor involved in the pathogenesis of HNSCC, where disease risk increases 
multiplicatively with intensity and duration of exposure to each (4). Although these 
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behaviors are positively and independently associated with the development of HNSCC, 
concurrent tobacco and alcohol use confers the greatest risk (4) and is associated with higher 
recurrence and mortality rates in those diagnosed with the disease (5-8).  
Prevalence of tobacco use in the United States declined rapidly between 1965 and 
2006, subsequent to the US Surgeon General’s warning regarding the role of tobacco in the 
development of lung cancer and other diseases (9), resulting in a decline in the incidence of 
HNSCC (10, 11). SEER data collected from 1975 – 2010 show a dramatic decline in the age-
adjusted incidence rates of SCCs of the larynx, floor of mouth, gum, and other mouth during 
this period. However, contrary to expectation, age-adjusted incidence rates of SCCs of the 
tongue and oropharynx/tonsil rose rapidly, with the sharpest increase in the past decade-and-
a-half (Figure 1.3) (http://www.seer.cancer.gov), and among young individuals, men, and 
white individuals (12). This change in HNSCC epidemiology indicates other factors are 
involved in HNSCC etiology (10).  
Emergence of Human Papillomavirus 
 
The decline in tobacco use in the 1960s coincided with reported sexual behavior 
changes by birth cohort in the United States, during which there was the emergence and 
increase in incidence of human papillomavirus (HPV) infection (12). These trends are 
hypothesized to be responsible for the shift in the epidemiologic landscape of HNSCC 
observed since the 1970s (10, 12). Although historically associated with cancers of the 
genitals (e.g. cervix and anus), we now appreciate that oral infection with a high-risk (i.e. 
oncogenic) strain of HPV, most often HPV-16, is the major etiologic factor responsible for a 
distinct subset of oropharyngeal HNSCCs.     
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A recent study using data from the 2009-2010 National Health and Nutrition 
Examination Survey (NHANES) data reported that approximately 7% and 1% of the U.S. 
population aged 14 – 69 were infected with any of 37 known high- and low-risk strains of 
HPV and oral HPV-16, respectively. 10% of men and 3.6% of women were orally infected 
with any strain of HPV. Risk of oral infection with a high-risk HPV strain increased with 
increasing number of lifetime sexual partners and current number of cigarettes smoked per 
day (12). Oral HPV-16 infection confers up to a 50-fold increased risk in disease 
development (13) and exerts its carcinogenic effects through integration of the viral DNA 
into the host genome, likely at fragile sites in chromosomes (14). Molecular studies show that 
integration of HPV results in the upregulation of the oncoproteins E6 and E7 (14), which 
inactivate the tumor suppressor proteins retinoblastoma (Rb) and protein 53 (p53) (10). E6 
zinc-binding motifs form a complex with host cell p53, prompting p53 degradation and 
preventing the induction of apoptosis in DNA-damaged cells, leading to uncontrolled cell 
growth (14). E7 complexes with hypophosphorylated forms of the host Rb protein, leading to 
a decrease in cellular Rb level and release of E2F, a transcription factor involved in cell cycle 
progression, resulting in overexpression of p16 (14).  
HPV-positive HNSCC is clinically and pathologically distinct from tobacco and 
alcohol-related, HPV-negative HNSCC (Figure 1-4). HPV is currently associated with an 
estimated 50-85% of oropharyngeal/base of tongue cancer cases (13, 15, 16) but is 
infrequently associated with other HNSCC sites, such as the oral cavity and larynx (15, 17, 
18). Histologically, HPV-positive tumors tend to be poorly differentiated with non-
keratinizing, basaloid features, while HPV-negative tumors tend to be more differentiated 
with keratinized morphology. HPV-positive tumors are typically found in younger 
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individuals with higher socioeconomic status and less lifetime exposure to tobacco and 
alcohol when compared to HPV-negative (19). Most significantly, studies report HPV-
positivity to be associated with enhanced response to treatment and lower mortality (15, 17-
21).  
Diet and Weight Status as Risk Factors 
 
Although to a lesser extent than tobacco, alcohol, and HPV, a number of studies 
indicate poor diet may play a role in the pathogenesis of HNSCC. Results from observational 
studies of individual foods suggest low consumption of fruits and vegetables (22-26), and 
high consumption of red and processed meats (22, 27) and dairy products (28) lead to 
increased risk of disease. In the largest prospective cohort study to date investigating the 
association between HNSCC risk and dietary fiber and grain intake, an inverse association 
between these foods and HNSCC incidence was found among women, but not among men 
(29).   
Studies of individual vitamins and minerals provide evidence that low intake of 
antioxidant micronutrients (A, C, E and carotenoids), minerals with anticancer properties 
(iron and zinc) and micronutrients involved in one-carbon metabolism (folate, riboflavin, 
vitamin B12) may also lead to increased risk of disease (30-33). The potential role of vitamin 
and mineral supplement intake on HNSCC risk was investigated in a pooled case-control 
study conducted by the International Head and Neck Cancer Epidemiology Consortium 
(INHANCE), but no strong associations between supplement use and HNSCC risk were 
observed (34). Dietary pattern analysis studies report reduced odds of developing HNSCC 
with high consumption of dietary patterns rich in fruits and vegetables and low in high-fat 
and processed meats and sweets (22). 
6 
 
Similar to other smoking-related cancers such as lung and bladder, weight status, as 
measured by body mass index [BMI = weight (kg) / height (m)
2
], measured at diagnosis (28, 
35, 36) and two years prior to diagnosis has been reported to be inversely associated with 
HNSCC (26, 37). Specifically, overweight or obesity (BMI >25kg/m
2
) appears to be 




Dietary Challenges of Head and Neck Squamous Cell Carcinoma Patients 
 
Data suggesting low BMI and inadequate dietary intake of fruits, vegetables, 
vitamins, and minerals are associated with increased risk of HNSCC development also 
suggest the nutritional status of HNSCC cases may be inadequate at the time of diagnosis. 
Inadequate nutritional status after HNSCC diagnosis is of concern due to several factors. 
First, smoking and alcohol use are highly prevalent in this patient population, and both drugs 
suppress appetite and the immune system, leading to decreased food intake and increased 
susceptibility to infection, respectively. Exposure to tobacco and alcohol generates reactive 
oxygen species in the body, which in turn depletes tissue stores of antioxidant micronutrients 
(38). Alcohol also interferes with the metabolism of several micronutrients important in 
cancer prevention and control, such as folate (add ref).   
Second, development of HNSCC may hinder the ability to eat as a result of side 
effects related to tumor location and treatment (38). Severe side effects prevalent in HNSCC 
patients that can impact dietary intake include difficulty swallowing (dysphagia), ulcerations 
of the oral mucosa (mucositis), altered taste (dysgeusia), decreased salivary production, 
(xerostomia) and dental problems (39-43). Post-surgical complications such as functional and 
anatomic chewing and swallowing impairments are also common (43-45).   
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Third, prevalence of cancer cachexia in the HNSCC population is high, with 
estimates ranging from 48 – 61% of all patients diagnosed with the disease. Cachexia, a 
wasting syndrome characterized by progressive skeletal muscle loss (with or without fat 
loss), functional impairment, and anorexia, is estimated to account for at least 20% of all 
cancer related deaths (46). The pathogenesis of cachexia is hypothesized to involve 
competition for nutrients between healthy host cells and tumor cells, leading to increased 
energy expenditure, protein and fat catabolism. This is facilitated by dysregulation of 
neuroendocrine hormones, and the release of tumor-derived catabolic factors and pro-
inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6, and 
interferon (IFN)-γ, resulting in muscle wasting and anorexia. Glucose intolerance and 
impaired insulin sensitivity are also commonly observed in cachectic patients (38, 46, 47). 
Diet and Head and Neck Squamous Cell Carcinoma Outcomes 
 
The nutritional challenges and complications observed in HNSCC patients likely have 
consequences for survival, and thus nutritional intervention may present an avenue to 
improve disease outcomes. However, little research has been conducted related to nutritional 
factors in HNSCC management and survivorship. Studies examining associations between 
diet and disease outcomes such as survival and recurrence in HNSCC patients are sparse but 
consistent with studies of diet as a risk factor for disease development, suggesting a positive 
influence of fruit (5) and vegetable (48, 49) intake and a negative influence of high red meat 
intake (49). Low pretreatment fruit but not vegetable intake was associated with decreased 
survival in one study (5) while data from two other studies suggest a protective effect of high 
vegetable but not fruit intake on risk of second primary cancers (48, 49) and survival (48). 
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High intakes of meat, liver and retinol are associated with increased risk of second primary 
cancers (49), but no data on the effect of these dietary factors on survival could be found.  
High-dose antioxidant supplementation may be detrimental to HNSCC patients 
undergoing radiotherapy as those supplemented with high-dose -tocopherol (400 IU/day), 
high-dose β-carotene (find amount), or a combination of both had a significantly increased 
incidence of second primary cancers (50) and decreased overall survival (51) in a 
randomized controlled trial. A recent case-control study showed that pre- and post-
radiotherapy plasma antioxidant (total carotenoids, -tocopherol and ascorbic acid) levels 
were significantly lower in HNSCC patients compared to healthy controls and decreased 
during radiotherapy. Plasma carotenoid levels were inversely associated with long-term 
survival (52). These data suggest dietary intake and nutrient levels may be associated with 
patient prognosis, but further research is warranted investigating these relationships between 
diet and HNSCC prognosis, how these relationships differ by disease subtype, and what 
molecular mechanisms underlie these relationships. This dissertation research addressed 
these gaps in knowledge through three Specific Aims. 
Specific Aims 
 
Aim 1.1: To identify major dietary consumption patterns in a population of incident cases of 
HNSCC, and to examine the association of these dietary patterns and weight status with 
recurrence and survival. 
 
As outlined above, few studies of HNSCC have examined diet as an independent 
prognostic indicator and in those studies only select individual foods and nutrients were 
investigated, as opposed to overall diet. Most people consume a variety of foods on a daily 
basis as opposed to large quantities of an isolated food or nutrient. The high collinearity 
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among nutrients and bioactive compounds found in foods proves disentangling their 
independent effects challenging; nutrients in food likely interact and work synergistically to 
produce a stronger effect on a disease outcome than any individually (53). Therefore, 
measures of overall diet in relation to disease outcomes as opposed to single foods and 
nutrients may be more useful. Studies suggest HNSCC patients with a BMI greater than 25 
kg/m
2
 at diagnosis have a survival advantage over those patients with a lower BMI (54, 55), 
but these studies lacked statistical power and measured BMI two years prior to HNSCC 
diagnosis. Understanding how overall dietary patterns and weight status influence HNSCC 
prognosis will have important clinical implications, allowing the development of dietary 
recommendations that are readily translatable to the clinic. These relationships were 
examined in the following hypotheses: 
Hypothesis 1.1: Diets rich in fruits, vegetables, lean meats, whole grains and poly and 
monounsaturated fats will be associated with lower recurrence and mortality rates.   
 
Hypothesis 1.2: Diets rich in red meat, saturated and trans fats, and processed foods will be 
associated with higher recurrence and mortality rates. 
 
Hypothesis 1.3: Higher BMI will be associated with lower recurrence and mortality rates. 
 
Aim 2.1: To compare pretreatment dietary intake of vitamins and minerals between newly 
diagnosed HNSCC patients with HPV-positive tumors to those with HPV-negative tumors. 
 
The basis for improved survival rates in HPV-positive HNSCC compared to HPV-
negative has not yet been established. It is unclear if HPV-positive tumors are less aggressive 
and more responsive to therapy than HPV-negative due to differing tumor biology, whether 
the prognostic advantage is due to healthier lifestyles exhibited by HPV-positive patients 
prior to diagnosis, or if it is a combination of both. Understanding variation in lifestyle 
behaviors between these two HNSCC subtypes may provide insight into mechanisms 
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underlying the observed prognostic differences, and highlight areas for intervention to 
improve outcomes in HPV-negative patients. Given the strong epidemiologic differences 
between patients with HPV-positive cancer and those with HPV-negative cancer, it is 
reasonable to hypothesize that diet plays a role in the more favorable outcomes of HPV-
positive patients. This issue was addressed by the following hypothesis: 
Hypothesis 2.1:  HPV-positive subjects will report higher pretreatment intake of key 
micronutrients with known anti-cancer properties than HPV-negative subjects. 
 
 
Aim 3.1: Examine associations between pretreatment serum cytokine levels and pretreatment 
dietary patterns, as well as reported intake and serum levels of carotenoids and vitamin E. 
Aim 3.2: Compare pretreatment cytokine levels between cachectic and non-cachectic 
HNSCC cases. 
 
A previous study reported that the pro-inflammatory cytokine interleukin-6 (IL-6) is 
positively associated with HNSCC recurrence and mortality. It is hypothesized that IL-6 
promotes the progression of HNSCC through mechanisms of carcinogenesis, angiogenesis, 
and metastasis, possibly through stimulation of cancer stem cell self-renewal. IL-6, TNF-α, 
and IFN-γ are also hypothesized to be involved in the pathogenesis of cachexia by increasing 
glucocorticoid production in the body and upregulating ubiquitin preteosome activity, 
leading to anorexia and increased proteolysis, respectively (47).  
Fruits, vegetables, and bioactive compounds found in fruits and vegetables, such as 
carotenoids and vitamin E are known to play a role in the physiological response to 
inflammation. It is possible these dietary compounds can mitigate the effects of 
proinflammatory cytokines in the body, reducing the likelihood of metastasis and cachexia 
and prolonging survival. If this hypothesis holds true, it would provide insight into a 
molecular mechanism underlying potential associations between diet and HNSCC survival 
11 
 
and serve as the basis for developing nutritional interventions aimed at preventing cachexia 
and prolonging HNSCC survival through the reduction of pro-inflammatory cytokines. 
Consequently, these associations were investigated in the following hypotheses: 
Hypothesis 3.1: A dietary pattern characterized by high intakes of fruits, vegetables, lean 
meats, whole grains and poly and monounsaturated fats, as well as high carotenoid intake and 
serum levels will be inversely associated with circulating serum cytokine levels. 
 
Hypothesis 3.2: A dietary pattern characterized by high intakes of red meat, saturated and 
trans fats, and processed foods will be positively associated with circulating serum cytokine 
levels. 
 
Hypothesis 3.3: Subjects with cachexia six months after HNSCC diagnosis will have higher 
pretreatment serum cytokine levels compared to non-cachectic subjects. 
 
Study Population: The University of Michigan Head and Neck Specialized Program of 
Research Excellence 
 
The study population for this dissertation research consists of two consecutive cohorts 
of HNSCC patients enrolled into the UM HN-SPORE between 2002 and 2012 at the 
University of Michigan Health System (UMHS) of Ann Arbor, the Veteran’s Administration 
Hospital of Ann Arbor, and the Henry Ford Hospital of Detroit.  The first cohort, referred to 
as SPORE 1, was recruited from all three sites. SPORE 1 data was used for Specific Aims #1 
and #2. The second cohort, SPORE 2, was recruited from only the UMHS site and data from 
this cohort was used for Specific Aim #3. 
The HN-SPORE was established in September 2002 through funding by the NCI and 
is one of only five such programs in the United States. The HN-SPORE’s interdisciplinary 
research team is comprised of physicians, dentists, and basic scientists with training in areas 
such as head and neck surgery, dental health, otolaryngology, medical and radiation 
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oncology, epidemiology, molecular biology, and biostatistics. The mission of this 
comprehensive research program is to significantly improve the diagnosis, treatment and 
prevention of HNSCC while decreasing morbidity and mortality associated with this disease 
(http://www2.med.umich.edu/cancer/hnspore).  
The HN-SPORE ascertains all newly diagnosed HNSCC patients who present at 
participating site clinics, with a catchment of ~27% of all new HNSCC cases in the state of 
Michigan, annually. The HN-SPORE houses an extensive longitudinal collection of 
information from over 1200 HNSCC patients, including epidemiologic, clinical, and 
molecular characterization. Eligible patients are recruited into the HN-SPORE at visits to the 
Otolaryngology, Radiation Oncology, Medical Oncology, and Speech Pathology clinics at 
UMHS and participating sites by trained HN-SPORE recruiters, nurses, or physicians. 
Informed consent is obtained and a medical record review is completed for each study 
participant.  
Epidemiologic data are collected from HN-SPORE participants using a self-
administered questionnaire collected at baseline and one-year; shortened versions of the 
questionnaire are collected at half-year intervals to update information. The epidemiologic 
data collected include: longitudinal data on smoking, alcohol use, diet, exercise, and sleep; 
clinical data on tumor site and stage, comorbidities, depression, quality of life, and 
recurrence status; and treatment modalities such as radiation therapy, surgery, chemotherapy, 
and combination therapy. Blood and saliva samples are collected every six months and tumor 






Dietary Assessment for Nutritional Epidemiology Studies 
 
There are many tools for dietary assessment in epidemiologic studies. The food 
frequency questionnaire (FFQ) remains the preferred method for measuring average dietary 
intake over a long period of time (typically a year) in large-scale epidemiologic studies due 
to its ability to rank individuals based on reported intakes at a reasonably low cost (56, 57). 
The most widely used FFQs include the Harvard FFQ (58) and the Block FFQ (59), both of 
which have been validated for use in many populations (58-63). However, multiple versions 
of the FFQ have been developed and differ slightly in design depending on such factors as 
the study population, gender, age group, and foods and/or nutrients of interest (57).  
Other common methods of dietary assessment in epidemiologic studies include 24-
hour recalls, food records, diet history and nutritional biomarkers. 24-hour recalls and food 
records collect detailed information on all foods and beverages consumed over the past 24 
hours. Both methods can more precisely quantify foods and nutrients eaten over a short 
period of time than the FFQ but must be collected at multiple time points to properly estimate 
usual diet due to variability in day-to-day intake (64). Repeat 24-hour recalls and food 
records are most valuable for describing mean values of groups and in evaluating the relative 
validity of FFQs (56). A “diet history” is any dietary assessment tool that asks the respondent 
to report on past diet (64). A diet history queries meal patterns, eating habits, food 
preparation practices and recent dietary changes, and results in more qualitative, rather than 
quantitative data (65). Biochemical measurements of nutrients in the blood can provide valid 
assessments of adequacy of dietary intake. However, this method of assessment should be 
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made on a nutrient-by-nutrient basis as not all nutrients have a valid biochemical indicator 
(56).  
For this dissertation research, an FFQ is the sole dietary assessment method used 
Specific Aims #1 and #2. In Specific Aim #3, biochemical measurements of serum 
carotenoids and tocopherols are also used in addition to an FFQ. Dietary intake is collected 
from all UM-SPORE Project 3 participants at baseline (diagnosis) and yearly-post-diagnosis 
using the self-administered, semi-quantitative Harvard FFQ, validated for use in several 
populations (56, 58, 61). This FFQ is a feasible instrument well suited to assess the 
associations of usual dietary intake with relevant lifestyle behaviors such as smoking and 
alcohol use (66). It has also been used extensively as a measure of dietary exposure in cancer 
studies (56). FFQ responses are used to rank individuals according to their usual 
consumption of foods, food groups and nutrients (64). It is relatively low-cost, easy to 
administer and can be completed on-site by the study participant or at home and returned by 
mail (67). The FFQ is designed to assess respondents’ usual dietary intake from food and 
supplements over the past year, reflecting seasonal variation in intake. Total energy and 
nutrient intake is estimated by summing up intakes from each food based on the given 
standard portion size, reported frequency of consumption and nutrient content of each food 
item (56).    
Conceptual Framework 
 
 Figure 1.5 outlines the conceptual framework for this dissertation research. Solid 
lines represent associations that have been established with prior research; dashed lines 
represent associations that are investigated herein. As illustrated in the figure, dietary intake 
and body mass index (BMI) at diagnosis may influence the likelihood of HNSCC survival 
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and recurrence. The associations between diet and prognosis and BMI and prognosis will be 
investigated in Specific Aim 1.1. Patients with HPV(+) HNSCC have a survival advantage 
over HPV(-) HNSCC and it is unknown whether diet plays a role in the prognostic 
discrepancies between these groups. This association will be explored in  Specific Aim 2.1. 
A decline in BMI may eventually lead to cancer cachexia, which in turn may increase 
likelihood of recurrence and mortality. Increased pro-inflammatory cytokine release has been 
hypothesized to promote tumor progression and to be involved in the pathogenesis of cancer 
cachexia by inducing skeletal muscle loss and a subsequent decline in BMI. Both of these 
pathways result in increased recurrence and mortality. As many dietary nutrients and 
bioactive food compounds have anti-inflammatory properties, it is possible diet can modulate 
circulating levels of pro-inflammatory cytokines in the body. Specific Aim 3.1 examines the 
association between diet and cytokine levels, and Specific Aim 3.2 examines the association 




Figure 1.1:  Tumor sites of the head and neck 
 








Figure 1.3: Age-adjusted incidence rates by cancer site; 1975 – 2010 
 






























CHAPTER 2  





Background: Few studies have evaluated the association of diet and weight status with head 
and neck cancer (HNC) outcomes.  
 
Objective: The purpose of this study was to determine if pretreatment dietary patterns and 
weight status are associated with HNC prognosis.   
 
Design: This was a longitudinal study of 542 newly diagnosed HNC patients who completed 
food frequency questionnaires (FFQ) and health surveys prior to treatment. Clinical data 
were abstracted from medical records and the Social Security Death Index. Dietary patterns 
were identified using principal component analysis. Cox proportional hazard models were 
used to examine the association of derived dietary patterns (fit by quintiles of exposure) and 
weight status with time to recurrence and survival, controlling for covariates.    
 
Results: During the study period there were 229 deaths and 184 recurrences. Two dietary 
patterns were identified: a “whole foods pattern”, characterized by high intakes of vegetables, 
fruits, fish, poultry and whole grains, and a “Western pattern”, characterized by high intakes 




analyses, significantly fewer deaths were observed in subjects most adherent to the whole 
foods pattern (HR 0.56, 95% CI 0.34 – 0.92, Ptrend=0.01). Subjects classified as overweight 
or obese had significantly fewer deaths (HR 0.65, 95% CI 0.49 – 0.85, P=0.001) and 
recurrences (HR 0.70, 95% CI 0.52 – 0.95, P=0.02) than normal or underweight subjects.  
 
Conclusions: Consuming a diet rich in vegetables, fruit, fish, poultry and whole grains and 




Although often combined into a single category, head and neck squamous cell 
carcinoma (HNSCC) is a heterogeneous disease that includes squamous cell cancers of the 
oral cavity, oropharynx, nasopharynx, hypopharynx and larynx.  Five-year HNSCC survival 
rates have remained steady at approximately 60%, likely due to late detection and high rates 
of persistent or recurrent disease. An estimated 50% of patients develop recurrence within the 
first two years after diagnosis (1, 2). Evidence suggests poor nutritional status and low 
consumption of foods and nutrients with chemopreventive properties increases the risk of 
developing HNSCC (4), but little research has investigated the roles of diet and weight status 
in HNSCC prognosis. Modifiable lifestyle factors such as diet and nutritional status may 
present a feasible approach for improving head and neck cancer survival and recurrence 
rates.  
Few studies have examined the association of HNSCC prognosis with individual food 
groups (e.g., fruits and vegetables) (5, 48) or nutrients (68-71). Most of these studies had 




examined overall dietary patterns.  Our group previously reported that low pretreatment fruit 
intake is negatively associated with survival in univariate analysis (5). It may be more 
informative to examine the combined, rather than individual, effects of dietary exposures on 
HNSCC prognosis as it is likely the many nutrients and nutritive compounds in food interact 
and work synergistically to produce a stronger effect than any individually (53). Examining 
overall dietary patterns is advantageous as it allows for the ability to relate usual intake of a 
range of nutrients to disease prognosis, and can be used as the basis for translational research 
aimed at developing population-specific nutritional interventions and dietary 
recommendations.   
Weight status as measured by Body Mass Index [BMI=weight(kg)/height(m)
2
] may 
be inversely associated with mortality, where patients classified as overweight or obese (BMI 
>25 kg/m
2
) at the time of HNSCC diagnosis have longer survival time when compared to 
similar patients with a lower BMI (54, 72-74). Previous studies investigating this association 
either had a small sample size (54), measured weight status several years prior to diagnosis 
(72) or did not consider recurrence as an outcome (72, 73).  
The objective of this study was to characterize pretreatment dietary patterns, and 
determine if dietary patterns and weight status predict recurrence and survival among 
HNSCC patients, controlling for other known prognostic factors such as demographics, 
smoking, problem drinking, cancer site and stage, comorbidities, and treatment.   The 
hypotheses were that diets high in fruits, vegetables, lean proteins and unprocessed foods, as 
well as overweight or obese status would be associated with better prognoses, while diets 
high in fat, processed foods and red meat, and normal or underweight status would predict 




Materials and Methods 
Design 
This was a prospective study of patients enrolled in the University of Michigan Head 
and Neck Cancer, Specialized Program of Research Excellence (UM HN-SPORE).  The 
independent variables of interest were pretreatment dietary patterns and weight status.  
Control variables were age, sex, cancer site and stage, treatment, comorbidities, smoking and 
total energy intake.  The dependent (outcome) variable was disease recurrence and all-cause 
survival.   
Study Population 
Patients newly diagnosed with HNSCC were recruited to participate in this study as 
part of the UM HN-SPORE.  Institutional Review Board approval was granted from the 
University of Michigan Health System (Ann Arbor, MI) the Veterans Affairs Healthcare 
System (Ann Arbor, MI), and the Henry Ford Health System (Detroit, MI). Patients were 
recruited between January 2003 and December 2008. Out of 1,185 patients approached, 934 
consented, yielding a response rate of 79%. Exclusion criteria included: 1) <18 years of age; 
2) pregnant; 3) non-English speaking; 4) diagnosed as mentally unstable; or 5) a diagnosis of 
another non-upper aerodigestive tract cancer. Patients who did not complete a baseline FFQ 
(n = 300), had previously diagnosed HNSCC (n = 40) and did not have a signed informed 
consent on file (n = 3) were excluded. The Rosner method was used to detect statistically 
influential outliers based on reported daily energy intake (75); n =5 participants were 
identified and excluded.  Comparative analyses of participant characteristics (chi-squared 
tests for categorical and t-tests for continuous variables) indicated that women reporting 




current smokers and have an alcohol problem than the rest of the study population. Since 
problem drinkers may be unreliable reporters, they were excluded from analyses (n = 44) to 
avoid potential systematic confounding. Though conservative, these upper bounds are 
considered reasonable for making exclusions based on energy intake (56). We did not 
exclude a priori based on a lower energy bound because the majority of participants 
presented to clinic with advanced cancers that may have hindered dietary consumption before 
diagnosis. Nevertheless, the lowest reported daily energy intake was 519 kcals/day, above the 
usual lower bound of 500 kcal. The final sample size included 542 newly diagnosed HNSCC 
patients.  
Procedures 
Participants completed a self-administered health questionnaire at baseline that 
collected data on demographics, tobacco use, alcohol use, physical activity, sleep, 
comorbidities, depression and quality of life. A medical record review was completed at 
baseline and annually for each study participant from which data on tumor site and stage, 
recurrence status, treatment modalities and survival were abstracted. 
Measures 
Predictors: Dietary Intake and Weight Status 
 
Dietary intake was collected using the self-administered, semi-quantitative Harvard 
FFQ, designed to assess respondents’ usual dietary intake from food and supplements over 
the past year. The reproducibility and validity of the 131-item questionnaire has been 
reported previously (56, 58, 61).  The FFQ includes standard portion sizes for each item [e.g., 




frequency of consumption over the past year from a list of nine choices ranging from “almost 
never” to “≥6 times per day”. Total energy and nutrient intake was estimated by summing 
intakes from each food based on the selected standard portion size, reported frequency of 
consumption, and nutrient content of each food item. Daily food group servings were 
estimated by summing the frequency weights of each food item based on reported daily 
frequencies of consumption (56).  Weight status was classified as overweight/obese (BMI 
>25 kg/m
2
) or normal/underweight (BMI ≤ 25 kg/m
2




Demographic variables were age, sex, race, level of education and marital status. 
Smoking data was categorized as current/former versus never” smoking and alcohol abuse 
was measured using the previously validated Alcohol Use Disorders Identification Test 
(AUDIT);  an AUDIT score ≥8 was considered problem drinking (76). Tumor site was 
recorded from operative notes and surgical pathology forms and categorized into three 
groups: 1) oral cavity, 2) pharynx and 3) larynx. In order to increase statistical power of 
stage-wise comparisons, cancer stage was categorized a priori into three groups, with TNM 
Stages 1 and 2 collapsed, while Stage 3 and Stage 4 were considered separately. 
Comorbidities were measured using the Adult Comorbidity Evaluation-27 and categorized 
into none or mild comorbidities versus moderate to severe comorbidities (77). Depression 
was measured using the 5-item Geriatric Depression Scale-Short Forms (GDS-SF) (78).  
Treatment was categorized into six groups to allow individual treatment approaches, 




3) surgery and radiation, 4) radiation and chemotherapy, 5) all treatment (surgery, radiation 
and chemotherapy), or 6) unknown treatment or none. 
Outcome: Survival and Recurrence 
 
Outcome variables were recurrence and overall survival. Follow-up was made with 
subjects every three months, allowing for tracking of patient status (alive or deceased). Each 
participant was censored from their last annual chart review as alive or deceased and 
recurrence or no recurrence as of February, 2012. Death and recurrence data were obtained 
from medical records and the Social Security Death Index (SSDI). Research assistants 
abstracted recurrence dates from medical records. Time to recurrence was calculated as the 
number of days from date of diagnosis to date of first recurrence. Patients with persistent 
disease were assigned a recurrence time of one day if they had completed treatment, but were 
never diagnosed as disease-free. 
Statistical Analysis 
 
 Descriptive statistics (means and frequencies) were generated for all demographic, 
epidemiologic and clinical variables. A Pearson’s correlation analysis was conducted 
between self-reported weights and weights abstracted from medical records among a random 
sample of 27 participants, showing excellent correlation between self-reported and clinical 
measures of weight (r = 0.98). Dietary intake data was assessed for missing values and 
energy outliers using standard techniques (56). Food consumption data derived from the FFQ 
were classified a priori into 39 foods and food groups using methods similar to those 




patterns present in the study population were derived by principal component analysis (PCA) 
using the orthogonal rotation procedure. In establishing the number of factors to retain in the 
final analysis, eigenvalues (≥3.0), Scree test, percentage of variability explained and 
interpretability of factors were considered (80). Pattern factor scores were calculated for each 
study participant by summing reported intakes of the factor food variables weighted by factor 
loadings. Dietary pattern scores were categorized into quintiles for analysis with survival and 
recurrence.   
 Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% 
confidence intervals (CI) for the associations of survival and recurrence with each retained 
dietary pattern and weight status. Previous evidence suggests differential associations of BMI 
and HNSCC mortality between smokers and non-smokers (72). As such, analyses also were 
conducted in which we stratified by smoking status (current/former versus never smokers). 
To avoid instability in estimating regression coefficients, potential covariates were assessed 
for collinearity by estimating Pearson’s correlation coefficients for continuous variables, Chi-
squared tests for categorical variables, or logistic regression between a dichotomous and a 
continuous variable. Exclusions of covariates in final models were made if they were highly 
correlated with other variables. Confounding was assessed by examining the association of 
each covariate individually with overall survival in univariate models. Any covariate with a 
p<0.10 was included in the next phase of modeling. Covariates were added to multivariable 
models one at a time, starting with the lowest p-value in univariate analysis, and included in 
the final models if addition of the variable altered the parameter estimate by >10% or if it had 
biological significance to the outcome.  Covariates considered for final models were age, sex, 




problem, multivitamin use and depression. Final models for survival and recurrence included 
age, sex, site, stage, treatment, comorbidities, and smoking. HR and CI were estimated for 
each quintile (Q) of dietary pattern score versus the lowest, Q1, and a test for trend across 
increasing quintiles of intake was performed. Dietary pattern and weight status variables 
were included in the same multivariable models to investigate the independent association of 
each with survival and recurrence.  All statistical analyses were performed in SAS 9.2 or 9.3.  
Results 
 
During longitudinal follow-up there were 229 death events (42.2%) and 184 
recurrence events (33.9%). Median follow-up time was 2199 days (≈6.0 years; Range 19 
days – 8.3 years). Overall epidemiological characteristics of the study population are 
displayed in Table 2.1. The mean age of study participants was 59 years. The majority of 
participants were White (92.6%), male (78.6%) and married (61.9%). Just over half of the 
participants were college graduates. The most common tumor location was the pharynx 
(56.3%) and most participants presented to our clinics with late-stage (III or IV) cancers 
(65.1%). Over 75% of participants were ever smokers, with about one quarter reporting an 
alcohol problem (24% with AUDIT score ≥ 8). Approximately 60% of patients were 
classified as overweight or obese at the time of diagnosis, slightly less than the proportion 
observed within the general U.S. population (68%) from 1999 – 2008 (81). 
 Two major dietary patterns were identified with PCA. The first pattern, termed the 
“whole foods pattern”, was characterized by high intakes of vegetables, fruits, legumes, fish, 
poultry, whole-grains, fruit juice, olive oil, nuts and garlic. The second pattern, termed the 
“Western pattern”, was characterized by high intakes of red and processed meats, refined 




desserts, snacks, mayonnaise and regular beverages. The factor-loading matrix for the two 
dietary patterns is presented in Table 2.2. 
Table 2.3 shows select characteristics of the study participants according to quintile 
of factor score for each dietary pattern. Patients in the highest quintile of whole-foods pattern 
score were more likely to have a higher BMI, be older, female, never smokers and more 
highly educated, and were less likely to have an alcohol problem than those in the lowest 
quintile. Patients with the highest whole-foods pattern scores also consumed more servings 
per day of fruits, vegetables, whole-grains, fish and poultry, and less total, saturated and 
trans fat. Conversely, patients in the highest quintile of Western pattern score were more 
likely to be younger, male, less educated, have an alcohol problem, and less likely to be 
never smokers than those in the lowest quintile. Patients in the highest quintile tended to 
consume more servings per day on average of red and processed meats, refined grains, 
potatoes and French fries, as well as more total fat than patients with low Western pattern 
scores. 
 Figure 2.1 shows the Kaplan-Meier curves for the association between each dietary 
pattern categorized by quintiles, survival and recurrence. Hazard ratios and 95% CI for 
survival and recurrence in association with the whole foods and Western dietary patterns are 
displayed in Table 2.4. There was a significant and increasing trend towards decreased risk 
of mortality across increasing quintiles of whole foods pattern score in multivariable 
analyses. Although there appeared to be a trend towards decreased risk of recurrence across 
increasing quintiles of whole foods pattern scores, this association did not reach statistical 
significance in multivariable analysis. There were no significant associations between 




In multivariable analyses, participants classified as overweight or obese prior to 
treatment
 
had significantly decreased risk of mortality and recurrence than patients classified 
as normal or underweight. Results shown in Table 2.5 are from the multivariate model that 
includes the whole foods dietary pattern as a covariate. The significant association between 
weight status and survival persisted in stratified analyses for both ever smokers and never 
smokers. The significant inverse association between recurrence and pretreatment BMI 
persisted for ever smokers, but was no longer significant for never smokers. Kaplan-Meier 
curves for the association between BMI and survival and BMI and recurrence for the total 
population, and stratified by smoking status, are displayed in Figure 2.2.  
Discussion 
 
This study showed that high whole foods dietary pattern score prior to treatment was 
associated with lower risk of recurrence and enhanced survival among HNSCC patients, 
independent of other factors known to influence prognosis. Being overweight or obese at the 
time of diagnosis was also associated with better prognosis, independent of diet. These 
results support and build on the work of prior studies.  A small prospective cohort study in 
Spain reported significantly reduced risk of recurrence, overall mortality and cancer mortality 
in participants consuming high levels of vegetables before and after diagnosis of oral cancer 
(48). Similarly, our prior work showed a trend of increased risk of death among HNSCC 
patients with low fruit intake, though this was not statistically significant in multivariable 
analysis.  Other studies have reported significant inverse associations between plasma 
carotenoids, specifically lutein, α-carotene, β-carotene (68) and lycopene (69) and HNSCC 
survival.  Our findings support the results of these studies as higher plasma carotenoid levels 




The foods that characterize the whole-foods pattern are rich sources of vitamins, 
carotenoids and polyphenols with known anticancer functions. Individually, many of the 
nutritive compounds abundant in these foods have been shown to reduce inflammation and 
oxidative stress in the body, maintain normal cellular processes such as cell growth, 
proliferation and apoptosis, inhibit angiogenesis and stimulate phase II detoxification 
enzymes to promote the excretion of carcinogenic compounds from the body (82, 83). All of 
these functions are shown to inhibit tumor growth, potentially explaining the associations 
between higher whole foods pattern score and reduced HNSCC mortality and recurrence. In a 
subset of this same HNSCC population, our group recently reported an association between 
hypomethylation of tumor suppressor genes and increased intakes of folate, vitamin B12, 
vitamin A and cruciferous vegetables (84). It is possible high consumption of foods 
characterizing the whole foods dietary pattern can alter the tumor DNA methylation profile 
in these patients, allowing tumor suppressor genes to continue being expressed and thus 
contributing to survival. 
There was no association between HNSCC prognosis and Western dietary pattern 
score. This result was unexpected, as high consumption of red and processed meats has 
previously been associated with cancer development (85) and mortality (86). It has been 
hypothesized high consumption of these foods is involved in tumor development and 
progression due to the carcinogenic actions of heterocyclic amines and aromatic 
hydrocarbons produced during cooking of red meat, and of nitrates and nitrites present in 
processed meats (87). One possible explanation for the lack of association between the 
Western pattern and prognosis is that many patients with high baseline Western pattern 




suggests many attempt to make positive lifestyle changes, including changes in diet, after a 
cancer diagnosis (88, 89). If patients decreased their consumption of foods included in the 
Western pattern and increased their consumption of foods included in the whole foods 
pattern, the potential adverse effect of a Western diet may have been countervailed by the 
protective effect of the foods with anticarcinogenic (and anti-metastatic) activities.  Future 
studies should address whether patients’ dietary patterns change after HNSCC diagnosis, 
throughout treatment and in the years following and how these potential changes affect 
prognosis.   
The finding that overweight and obese pretreatment BMI was associated with 
decreased risk of mortality and recurrence in the total study population supports findings of 
data collected from the larger Cancer Prevention Study-II cohort and the Nutrition cohort 
case-control study (72), as well as evidence from two smaller cohort studies of HNSCC 
patients (54, 73). The mechanisms underlying the association of higher BMI with lower 
recurrence and mortality are unclear. It is estimated over 50% of patients with advanced 
HNSCC experience significant weight loss and cachexia during the course of disease (46). 
Marked weight loss and cachexia is associated with increased susceptibility to infection and 
treatment-related toxicity, and with a reduction in quality of life and likelihood of survival 
(90). The increased fat and energy stores of overweight and obese patients may help them to 
withstand deterioration in nutritional status resulting from cachexia and rigorous treatment 
regimens (54). 
To our knowledge, this is the largest study to date examining the association between 
diet and HNSCC prognosis and the first to relate overall dietary patterns to HNSCC 




factors are strengths of this study. While the observational study design allows for the 
determination of an association between dietary patterns and weight status with disease 
prognosis, it does not demonstrate causality.  Our work has previously suggested significant 
differences in survival by cancer site, where patients with laryngeal cancer had the best 
survival (5, 91), however, in this analysis we report no significant difference in survival by 
cancer site perhaps due to the longer follow up time as we continue this longitudinal study. 
The heterogeneous nature of the study population in regard to tumor site is a 
limitation, but we were able to control for site in the final models and the large numbers of 
patients allowed for good statistical power. While we did not have biochemical verification 
for smoking status, our work (92) and the work of others (93, 94) has shown greater than 
90% sensitivity and specificity for self-reported versus biochemical validation of smoking 
status, with low misclassification rates, thus, self-reported smoking status was thought to be 
sufficient; especially since it is a covariate and not the main variable of interest. Although 
BMI was based on self-reported measures of height and weight, several studies show strong 
correlation between self-reported and clinical measures of these variables (95-97). A random 
sampling of 27 of our own participants showed excellent (r=0.98) agreement between self-
reported and clinically measured weights.  
There was insufficient statistical power to examine HPV as a confounding or effect 
modifying factor, but controlling for site could be considered a reasonable surrogate for HPV 
status, as it is likely up to 80% of oropharyngeal cases were HPV(+) (12). While the FFQ 
used to measure diet is susceptible to measurement error leading to misclassification bias, 
this type of bias is likely to attenuate associations towards the null (56).  Because patients 




related to social desirability, stress of the diagnosis, or concerns about contributing to their 
own disease could have occurred. While recall bias is a concern, previous studies of diet and 
breast cancer indicate either little evidence of recall bias (98, 99), or that the measures of 
association are attenuated when recall bias occurs (100). Future research in HNSCC 
populations should be conducted to determine if dietary recall bias exists and how it may 
influence study results. Despite recruitment efforts at an inner city and Veterans Affairs 
hospital, the study population consisted predominantly of White males thus the results may 
not be generalizable to racially diverse HNSCC populations.  
 In conclusion, consuming a diet high in vegetables, fruits, fish, poultry, and whole 
grains, as well as overweight or obese status at diagnosis with HNSCC is associated with 
reduced mortality and recurrence. Patients consuming low amounts of foods included in the 
whole foods dietary pattern, or with normal or underweight status may benefit from more 
aggressive surveillance throughout the disease trajectory. Results of this study highlight the 
need for randomized controlled trials aimed at optimizing the likelihood of a favorable 









Table 2.1: Pretreatment Characteristics of Newly 
Diagnosed Head and Neck Cancer Patients 
Characteristic No. of Patients 
(n = 542) 
% 
Follow-up time, days   
     Median 2199  
     Range 19 - 3067  
Age, years   
     Mean 59  
     SD 11  
     Range 21 - 92  
Sex   
     Male 426 78.6 
     Female 116 21.4 
Race   
     Non-Hispanic white 502 92.6 
     Non-white/Hispanic 40 7.4 
Education   
     High School or Less 248 45.9 
     Some College or More 292 54.1 
Marital Status   
     Married 335 61.9 
     Not Married 206 38.1 
Site   
     Oral Cavity 118 21.8 
     Pharynx 305 56.3 
     Larynx 119 21.9 
Stage   
     1,2 112 20.7 
iiii3 77 14.2 
iiii4 353 65.1 
Treatment   
     Surgery only 77 14.2 
     Radiation only 47 8.7 
     Surgery + radiation 66 12.2 
     Radiation + chemotherapy 214 39.5 
     All treatment 124 22.9 
     Unknown treatment or none 14 2.5 
ACE-27 Comorbidity Score  
     None or mild 364 67.2 
     Moderate or severe 178 32.8 
Smoking   
     Current 117 21.4 
     Former 306 56.1 




Alcohol Problem (AUDIT ≥8)  
     Yes 130 24.0 
     No 412 76.0 
BMI (kg/m
2
)   
     Underweight (<18.5) 19 3.5 
     Normal weight (18.5 - 24.9) 195 36.0 
     Overweight (25 - 29.9) 205 37.8 
     Obese (≥30) 123 22.7 
Multivitamin Use   
     Current 265 48.9 
     Past 105 19.4 
     Never 172 31.7 
Depression   
     Depressed 270 49.8 
     Not depressed 257 47.4 
     Unknown 15 2.8 
Fruit and Vegetable Intake (servings/day) 
     0 – 1 43 7.9 
     >1 – 3 249 45.9 
     >3 – 5 149 27.5 






























Table 2.2: Factor Loading Matrix† 
Food Group Whole Foods Western 
Green Leafy Vegetables 0.74 -0.05 
Other Vegetables 0.69 0.19 
Dark Yellow & Orange Vegetables 0.66 -0.01 
Fruit 0.64 -0.13 
Cruciferous 0.63 -0.05 
Legumes 0.60 0.12 
Tomatoes 0.52 0.09 
Fish 0.47 0.10 
Poultry 0.42 0.14 
Whole Grains 0.41 0.09 
Salad Dressing 0.37 0.13 
Olive Oil 0.37 -0.13 
Fruit Juice 0.34 -0.04 
Nuts 0.33 0.09 
Garlic 0.30 0.07 
Low-fat Dairy 0.28 -0.20 
Cereal 0.28 -0.03 
Wine 0.24 -0.12 
Tea 0.21 -0.05 
Beer -0.22 0.17 
Red Meats 0.01 0.62 
Refined Grains -0.03 0.59 
Processed Meats -0.06 0.52 
French Fries -0.13 0.48 
Potatoes 0.02 0.47 
Condiments -0.03 0.43 
High-fat Dairy 0.04 0.42 
Margarine -0.08 0.38 
Butter -0.15 0.36 
Eggs 0.14 0.35 
Coffee 0.07 0.33 
Desserts -0.01 0.32 
Snacks 0.16 0.31 
Mayonnaise 0.14 0.30 
Regular beverages -0.16 0.30 
Creamy Soups & Chowder 0.06 0.25 
Pizza 0.05 0.24 




Diet Beverages 0.07 0.09 
Liquor -0.04 0.08 
†Bolded numbers signify factor loadings ≥0.30 and considered to be major 





Table 2.3: Selected Characteristics and Dietary Intakes of Subjects by Quintile (Q) Dietary Pattern Score (n  = 542)†  
  Whole Foods Pattern Western Pattern  
  Q1 Q2 Q3 Q4 Q5 Q1 Q2 Q3 Q4 Q5  
n 108 109 108 109 108 108 109 108 109 108  
Clinical Characteristic                      
    Age (mean) 57.0 59.4 59.1 59.7   61.1 61.3 59.2 61.1 58.6 56.2‡  
    BMI (kg/m
2
, mean) 25.2 26.9 27.0 27.0 27.7* 26.0 27.2 26.7 26.9 26.9 
 
    Female (%) 13.9 17.4 22.2 25.7 27.8 29.6 23.8 19.4 18.3 15.7  
    Stage 4 (%) 71.3 70.6 62.0 65.1 56.5 63.9 71.6 53.7 67.0 69.4  
    ≤ High School/GED education (%) 67.3 45.4 40.7 45.9 30.6‡ 30.6 47.7 38.7 60.5 51.8‡  
    Never smokers (%) 15.7 19.3 24.1 22.9 32.4‡ 28.7 27.5 23.1 18.3 16.7*  
    Alcohol Problem (%) 45.4 24.8 21.3 18.3 10.2‡ 14.8 23.8 23.1 26.6 31.5  
    Current Multivitamin Use (%) 35.2 49.5 51.8 53.2 54.6 64.8 55.0 41.7 43.1 39.8‡  
    Depressed (%) 50.9 45.9 51.8 53.2 47.2 53.7 50.5 52.8 55.0 37.0  
Mean Food Intake (servings per day, 
energy-adjusted)                     
 
    Total fruit 0.4 0.8 1.0 1.4 1.7‡ 1.5 1.1 1.0 0.9 0.7‡  
    Total vegetables 1.2 1.6 2.1 2.7 4.3‡ 2.9 2.5 2.3 2.0 2.1‡  
    Whole-grains 0.5 0.9 1.1 1.2 1.3‡ 1.2 1.1 1.2 0.9 0.8‡  
    Fish 0.1 0.2 0.2 0.2 0.3‡ 0.2 0.2 0.2 0.2 0.2  
    Poultry 0.2 0.3 0.4 0.4 0.5‡ 0.4 0.4 0.4 0.3 0.4  
    Red and processed meats 1.2 1.1 1.1 0.9 0.8‡ 0.8 0.9 1.0 1.2 1.3‡  
    Refined grains 1.3 1.4 1.3 1.0 0.9‡ 0.9 1.0 1.1 1.2 1.7‡  
    Potatoes and French fries 0.4 0.4 0.4 0.3 0.3‡ 0.3 0.4 0.4 0.4 0.5‡  
Mean Nutrient Intake (grams per day, 
energy-adjusted)                     
 
    Total energy (kcals) 1789 2020 2136 2357 2590‡ 1414 1815 2155 2451 3057‡  
    Total carbohydrate 235 252 255 268 268‡ 267 266 264 244 238‡  
    Total protein 77 83 89 86 96‡ 87 85 85 86 89‡  




    Saturated fat 31 30 29 27 25‡ 26 27 27 31 31‡  
    Monounsaturated fat 31 32 31 30 31 31 29 30 33 34‡  
    Polyunsaturated fat 13 14 14 15 14‡ 13 13 14 14 15‡  
    trans fat 3.4 3.5 3.4 3.1 2.6‡ 2.8 3.0 3.3 3.6 3.4‡  
 
†P-values were derived by using a chi-square test for categorical variables and by using the Kruskal-Wallis test for continuous variables 
*P  < 0.05 





Table 2.4: Multivariate HR and 95% CI According to Quintile (Q) of Dietary Pattern Score for Survival and Recurrence 
Events 
  Q1 Q2 Q3 Q4 Q5 P*   
n 108 109 108 109 108     
Survival               
     Whole Foods Pattern               
          Univariate 1.0 0.88 (0.60, 1.3) 0.81 (0.55, 1.19) 0.70 (0.47, 1.05) 0.56 (0.37, 0.86) 0.004   
          Multivariate† 1.0 0.81 (0.54, 1.23) 0.88 (0.58, 1.35) 0.65 (0.42, 1.03) 0.56 (0.34, 0.92) 0.01   
     Western Pattern†               
          Univariate 1.0 0.98 (0.65, 1.49) 1.11 (0.74, 1.67) 1.05 (0.70, 1.57) 0.98 (0.65, 1.48) 0.99   
          Multivariate† 1.0 1.11 (0.71, 1.72) 1.02 (0.65, 1.60) 1.03 (0.62, 1.70) 0.90 (0.49, 1.68) 0.70   
Recurrence               
     Whole Foods Pattern†             
          Univariate 1.0 0.88 (0.57, 1.36) 0.87 (0.56, 1.30) 0.75 (0.48, 1.17) 0.60 (0.38, 0.97) 0.03   
          Multivariate† 1.0 0.87 (0.55, 1.38) 0.98 (0.61, 1.57) 0.78 (0.47, 1.29) 0.66 (0.38, 1.16) 0.13   
     Western Pattern†               
          Univariate 1.0 1.39 (0.89, 2.17) 1.08 (0.68, 1.73) 1.02 (0.64, 1.64) 0.98 (0.61, 1.58) 0.48   
          Multivariate† 1.0 1.51 (0.95, 2.41) 1.01 (0.60, 1.69) 0.91 (0.52, 1.61) 0.82 (0.42, 1.61) 0.24   
 
†Adjusted for age, sex, tumor site, cancer stage, treatment, ACE-27 comorbidities, smoking, BMI and total energy intake       
*P-value represents a trend test across quintiles of dietary pattern. Each individual's dietary pattern score was set to the median score for that quintile, and 






Table 2.5: Multivariate HR and 95% CI  of Pretreatment Body Mass Index >25 kg/m
2 
(overweight/obese) for Recurrence and Survival Events 
  Survival Recurrence 
  HR 95% CI P* HR  95% CI P* 
Total population† 0.65 0.49, 0.85 0.001 0.7 0.52, 0.95 0.02 
Ever smokers‡ 0.60 0.45, 0.81 <0.001 0.66 0.48, 0.92 0.01 
Never smokers‡ 0.35 0.13, 0.91 0.03 0.54 0.22, 1.36 0.19 
†Adjusted for age, sex, tumor site, cancer stage, treatment, ACE-27 comorbidities, smoking, whole foods dietary pattern 
and total energy intake 
‡Adjusted for age, sex, tumor site, cancer stage, treatment, ACE-27 comorbidities, whole foods dietary pattern and total 
energy intake 























Figure 2.1: Kaplan-Meier curves of survival and recurrence for dietary patterns. (A) Survival 
by quintile of whole foods pattern score; (B) Recurrence by quintile of whole foods pattern 
score; (C) Survival by quintile of western pattern score; (D) Recurrence by quintile of 












Figure 2.2: Kaplan-Meier curves of survival and recurrence for BMI category. (A) Survival 
by BMI category of overall population; (B) Recurrence by BMI category of overall 
population; (C) Survival by BMI category of ever smokers; (D) Recurrence by BMI category 
of ever smokers; (E) Survival by BMI category of never smokers; (F) Recurrence by BMI 









Higher micronutrient intake is associated with human papillomavirus-positive head 




Background: No studies have investigated dietary differences between head and neck 
squamous cell carcinoma (HNSCC) patients with human papillomavirus (HPV)-positive 
tumors and patients with HPV-negative tumors.  
 
Objective: This study was designed to investigate the relationship between diet and HPV 
status in HNSCC patients.  
 
Design: Cases of HNSCC were recruited from two clinical centers participating in the 
University of Michigan Head and Neck Specialized Program of Research Excellence 
(SPORE). HPV tissue genotyping was performed and epidemiologic and dietary data 
collected. Multivariable logistic regression tested whether pretreatment consumption of 12 
selected micronutrients was significantly associated with HPV-positive status in 143 patients 
newly diagnosed with cancer of the oral cavity or pharynx.  
 
Results: After controlling for age, sex, body mass index, tumor site, cancer stage, problem 




between vitamin A, vitamin E, iron, β-carotene and folate intake and HPV-positive status 
(Ptrend<0.05).  
 
Conclusions: HPV-positive HNSCC cases report higher intake of key micronutrients with 
anti-cancer and anti-metastatic properties compared to HPV-negative cases. These results 
support the hypothesis that differences in lifestyle characteristics may be a factor in the 
survival discrepancies observed between these two HNSCC subtypes. Dietary differences by 
HPV status should be considered in prognostic studies to better understand the influence of 





While tobacco and concurrent alcohol use accounts for the majority of all cases of 
head and neck squamous cell carcinoma (HNSCC) in many populations, the oncogenic 
human papillomavirus (HPV)-16 contributes to a distinct subtype of the disease (13, 101-
105). HPV-associated tumors accounted for more than 50% of the squamous cell carcinomas 
of the oropharynx in the United States prior to 2005 (104). Recent data show that the 
proportion of HPV-positive oropharynx cancers is continuing to increase. Among a cohort of 
oropharyngeal cancer cases followed by our group from 1999-2002, 64% entered into a 
clinical trial of induction chemotherapy followed by concurrent cisplatin and radiation, had 
HPV-positive tumors (101). In the consecutive cohort entered from 2002-2007 into our 
subsequent trial of concurrent cisplatin, taxol and radiation, 82% of the oropharynx cancers 
contained high-risk HPV (15). HPV-associated head and neck cancers are infrequently 




suggests that these two distinct subtypes of HNSCC are characterized by different risk 
profiles and clinical outcomes. HPV-positive tumors are typically found in individuals with 
less exposure to tobacco, and have been associated with improved long-term survival when 
compared with HPV-negative, more strongly tobacco-related tumors, independent of 
treatment modality (15, 17, 18, 106-109).  HPV-positive cases with a more extensive 
smoking history may experience reduced disease-specific survival and increased risk of 
disease recurrence than their non-smoking counterparts (15, 110). 
Risk factors for HNSCC other than tobacco use and HPV infection have been 
identified. Inadequate intake of certain micronutrients and foods may contribute to the 
development of HNSCC, while adequate intake may be protective (111). Evidence for 
inverse associations between oral and pharyngeal cancer and dietary consumption of several 
micronutrients includes associations for the antioxidant vitamins A, C, E and carotenoids (32, 
111-113); minerals such as iron, calcium and zinc (30, 32, 111, 113-115); folate (31, 32); and 
riboflavin (30, 114, 115). Several studies have reported inverse associations between oral and 
pharyngeal cancer risk and fruit and vegetable intake (23, 112, 114, 116, 117). Furthermore, 
low fruit intake may be associated with reduced survival in cases diagnosed with HNSCC 
(5), and high vegetable intake may reduce the risk of recurrence and mortality in oral cancer 
cases (48).   
Although improved prognoses have been documented in HNSCC cases with HPV-
positive tumors, the basis for this survival advantage has not been well established. The 
discrepancy in survival rates by HNSCC subtype may be due to differences in tumor biology, 
differences in lifestyle characteristics, or a combination of both. Epidemiologic studies 




characteristics—they are younger, have lower exposure to tobacco and alcohol, and have 
higher education and socioeconomic status (SES) than individuals with tobacco-related 
tumors (13). These data suggest that diet may differ between subjects with HPV-positive 
tumors and subjects with HPV-negative tumors, as diet quality is generally associated with 
SES and lifestyle (118, 119). Hence, this case-only analysis was conducted to determine if 
differences exist in dietary intake of key micronutrients with known anti-cancer and anti-




This was a cross-sectional study of cases enrolled in the University of Michigan Head 
and Neck Cancer, Specialized Program of Research Excellence (SPORE).  The independent 
variables were total intake, from food and supplements, of 12 micronutrients: vitamins A, C, 
D, B12, -carotene, calcium, iron, zinc, copper, riboflavin, and folic acid.  Confounding 
variables included age, sex, race/ethnicity, educational level, body mass index 
[BMI=weight(kg)/height(m)
2
], smoking, problem drinking, tumor site, and cancer stage.  The 
outcome variable was HPV status (positive or negative). 
Study Population 
Newly diagnosed cases with squamous cell carcinoma of the head and neck were 
recruited to participate in this study.  Cases were recruited from the Ann Arbor Veterans 
Affairs Hospital and the University of Michigan Hospital.  Exclusion criteria included: 1) < 
18 years of age; 2) pregnant; 3) non-English speaking; 4) diagnosed as mentally unstable; 5) 




or 6) a previous diagnosis and treatment for head and neck cancer.  Out of 1,185 cases 
approached, 934 consented to participate yielding a response rate of 79%.   
Tumors with adequate tissue for microdissection were available from 205 cases, and 
203/205 (99%) had amplifiable DNA as assessed by PCR amplification of beta-globin. Of 
these 203 cases, 193 had completed a self-administered food frequency questionnaire (FFQ) 
at presentation (58). No laryngeal tumors contained integrated HPV.  Therefore 50 
individuals with larynx tumors were excluded, leaving a total of 143 subjects in the current 
analysis. Human subjects approval was received from the institutional review boards at each 
institution.   
Procedures 
Research assistants recruited cases to the study in the waiting rooms of 
otolaryngology clinics.  Informed consent was obtained and epidemiologic data were 
collected using a self-administered questionnaire, as has been previously described (120).  A 
medical record review was completed for each study participant. Dietary intake was collected 
using a self-administered, semi-quantitative FFQ, validated for use in several populations 
(56, 58, 61).    
Tumor blocks were recut for uniform histopathologic review and microdissection, 
with the first and last slides of a series of 12 reviewed by a qualified pathologist to confirm 
the original diagnosis and to circle areas for microdissection. Percent cellularity was 
estimated for each tumor and areas with >70% cellularity of cancer were designated for 
cancer microdissection.  
HPV genotyping was performed using the GP5+/GP6- PCR reverse line blot (RLB) 




PCR for beta-globin as a positive control. All runs included positive and negative controls for 
HPV, as well as water controls to exclude the possibility of contamination. All HPV assays 
were repeated at least twice for quality assurance and quality control, with perfect 
correspondence. A subset of tumors also had frozen tumor available, and independent HPV 
assays were performed on these tumors. 
Measures 
The 131-item FFQ was designed to assess respondents’ usual dietary intake from 
food and supplements over the past year. Total energy and nutrient intake was estimated by 
summing intakes from each food based on the given standard portion size, reported 
frequency of consumption, and nutrient content of each food item (56). As the FFQ has not 
been validated in HNSCC populations, reliability of energy reporting using this tool is 
unknown. Because the majority of cases had advanced tumors (stage 3 or 4) upon entering 
the study, self-reported dietary intake may be reflective of recent dietary changes due to 
disease progression, rather than actual intake over the past year. Therefore, we chose to use a 
surrogate measure of energy intake in this analysis as opposed to self-reported energy intake 
from the FFQ. The population-adjusted total energy expenditure (PATEE), developed by 
Hebert et al, is based on an individual’s basal metabolic rate (BMR; as calculated by the 
Harris-Benedict equation), and is weighted by age group-specific median caloric intakes as 
reported by the National Health and Nutrition Examination Survey (123, 124). PATEE was 
developed for use in the Women’s Health Initiative (124). Originally designed for use as a 
proxy when reported FFQ energy intake (FFQEI) data are missing (125), the current 
refinement has been validated in a cohort of subjects on which total energy intake was 




individual and Pearson correlation coefficients were computed to measure the strength of the 
linear relationship between FFQEI and PATEE, which was found to be excellent (b = 0.92; 
SEb = 0.20) (124).  
Smoking data permitted analysis by “current-past-never” smoking and cumulative 
pack-years. Cumulative pack-years was coded as ≤ 30 pack-years or > 30 pack-years 
(median) to avoid problems due to non-normality. Alcohol consumption was measured using 
the previously validated Alcohol Use Disorders Identification Test (AUDIT) (76). An 
AUDIT score ≥8 was considered problem drinking. Tumor site was recorded from operative 
notes and surgical pathology forms. For the purposes of data analysis, tumor site was 
categorized into oral cavity, pharynx, or larynx. Cancer stage was categorized a priori into 
three groups, with Stages 1 and 2 considered together, and Stage 3 and Stage 4 considered 
separately, enhancing power of comparisons by stage.  
Statistical Analysis 
Descriptive statistics were generated for all variables (means and frequencies) and 
bivariate analyses were conducted to determine differences in demographic characteristics 
between individuals with HPV-positive tumors and HPV-negative tumors. Students t-tests 
were conducted to test whether the two study groups differed significantly by age and BMI.  
To test whether the two groups differed significantly by sex, race, education, smoking, 
alcohol problem and tumor site, chi-square tests were performed. The Wilcoxon rank-sum 
test was utilized to determine if the HPV-positive and HPV-negative study groups differed 
significantly by tumor stage. Multivariable logistic regression models were fit to test whether 
pretreatment intake of twelve select micronutrients was significantly associated with HPV-




supplements and quartiles of intake from foods only. Categorical variables were created for 
sex (male vs. female), tumor site (pharynx vs. oral cavity), cancer stage (stage 1 or 2; stage 3; 
stage 4), smoking (current-past-never) and problem drinking (none vs. any). A test for trend 
across increasing quartiles of total dietary intake from food and supplements was performed 
with an alpha level of 0.05 considered significant. A similar test for trend was performed for 
dietary intake from food sources only. Covariates adjusted for included age, BMI, PATEE, 
sex, tumor site, smoking and problem drinking. Education was considered as a covariate, but 
did not influence the significance of the model.  A sensitivity analysis was conducted for the 
association between each micronutrient with HPV status, controlling for the remaining 
micronutrients. To address correlation among micronutrient intakes, a principal components 
analysis was performed for the remaining micronutrients, and the top three factors were 
included in the multivariable model. In all models, these three factors accounted for at least 
75% of the variability in the remaining variables (77-81%). All analyses were performed 
using SAS software (SAS 9.1, SAS Institute, Cary, NC).   
Results 
 
 The majority of the study population was European American (93%) and male (80%). 
Ever smoking and problem drinking were highly prevalent in this population (77% and 31%, 
respectively). Cases were more likely to have stage 3 or stage 4 tumors than stage 1 or 2 at 
presentation to clinical centers.  
Table 3.1 compares epidemiologic characteristics of those cases with HPV-positive 
tumors to those with HPV-negative tumors. The vast majority of HPV-positive cancers were 
found in the pharynx. Individuals with HPV-positive tumors appeared to have a higher mean 








p=0.08). Distribution of “ever” vs. “never” smoking did not differ significantly by HPV 
status. HPV-positive cases were less likely to be current smokers (p=0.05), and tended to 
have smoked for less than the median number of pack-years (p=0.07). A greater percentage 
of individuals with HPV-negative tumors reported they had an alcohol problem than did 
individuals with HPV positive tumors (36.2% and 18.4%, respectively; p=0.04). Distribution 
of HPV status did not differ significantly with respect to age, sex, cancer stage, race or 
highest education attained. 
 Mean estimated BMR differed significantly between HPV-positive and HPV-negative 
individuals (mean=1534 and 1446, respectively; p=0.02), while mean FFQEI and PATEE did 
not differ significantly by HPV status. FFQEI and PATEE were not well correlated with one 
another (r = 0.17, r = 0.09 and r = 0.19 for total, HPV-positive and HPV-negative, 
respectively). However, controlling for FFQEI instead of PATEE in the multivariable models 
did not significantly change the quartile-specific odds ratios and Ptrend for each respective 
micronutrient (results not shown). 
 Because micronutrients were modeled as quartiles of intake, the cut point for each 
quartile is listed in Table 3.2 for total nutrient intake from food and supplements and for 
nutrient intake from food sources alone. After controlling for age, sex, BMI, tumor site, 
cancer stage, smoking, problem drinking and PATEE, a significant association was observed 
between HPV-positive status and increasing quartiles of intake from food and supplements 
for vitamin A (OR = 22.41 for the highest quartile versus the lowest quartile; Ptrend = 0.003), 
vitamin E (OR=3.84; Ptrend = 0.04), -carotene (OR = 3.86; Ptrend = 0.02), iron (OR = 14.45; 
Ptrend = 0.003) and folate (OR = 8.97; Ptrend = 0.02) (Table 3). Associations between HPV 




B12 were not significant. The results did not substantially differ when considering 
micronutrient intakes from food sources alone. After adjustment for the remaining 
micronutrients in a sensitivity analysis, vitamin A and iron remained significant predictors of 
HPV status.  
Discussion 
 
In this study of HNSCC cases, we observed a significant and positive association 
across quartiles of intake and HPV-positive status for total nutrient intake from food and 
supplements, and intake from food sources alone of vitamin A, vitamin E, β-carotene, iron 
and folate. These results indicate that cases with HPV-positive tumors consume significantly 
higher levels of key micronutrients with anti-cancer functions compared to cases with HPV-
negative tumors. Sensitivity analyses indicated that, regardless of overall micronutrient 
intake, vitamin A and iron predicted HPV status.   
HPV-positive head and neck cancer cases generally have lifestyle characteristics that 
are associated with better overall health than the lifestyle characteristics of HPV-negative 
cases.  For example, HPV-positive cases typically have a higher SES and less lifetime 
exposure to tobacco and alcohol compared to HPV-negative cases. Higher SES and less 
tobacco use and alcohol consumption are generally associated with better overall diet quality 
(118, 119).  This is also seen in our study, where HPV-positive cases have a less extensive 
history of smoking and alcohol abuse than do HPV-negative cases. Our finding that HPV-
positive cases report consuming higher levels of vitamin A, vitamin E, β-carotene, iron and 
folate support the existing epidemiologic evidence that HPV-positive HNSCC cases exhibit 
lifestyle characteristics associated with better overall health, and that these healthier 




Other than supporting previous evidence that HPV-positive and -negative HNSCC 
cases display different lifestyle characteristics and risk profiles, the observed differences in 
micronutrient intake between the two groups have other potential implications. Higher intake 
of the observed micronutrients, or foods rich in the observed micronutrients, could make an 
individual more susceptible to oral HPV infection. A prior study reported that HPV-16 
seronegative individuals with high fruit or citrus intake were significantly less likely to 
develop HNSCC than those with low fruit or citrus intake, but that the opposite was true for 
HPV-16 seropositive individuals (i.e. high fruit and citrus intake was associated with greater 
risk of HNSCC development in HPV-16 seropositive individuals).  The authors hypothesized 
a mechanism by which citrus fruit and other highly acidic foods may erode the mucosal 
lining of the gastrointestinal tract, increasing the probability of HPV infection (126).  
Another study reported that while higher plasma levels of carotenoids were associated with a 
43% to 50% reduction in the risk of initial anal HPV infection, once infected higher levels of 
carotenoids and retinol were associated with decreased clearance of persistent anal HPV 
infection (127). This evidence is consistent with our finding that higher intakes of vitamin A 
and β-carotene are associated with HPV-positive HNSCC.  
Higher intakes of vitamin A, vitamin E, β-carotene, iron and folate may 
independently influence the better prognosis of HPV-positive cases and this possibility 
should be explored in the future. There are several mechanisms by which adequate dietary 
intake of vitamin A, β-carotene, iron, and folate may contribute to better clinical outcomes in 
HNSCC cases. Two previous studies reported that higher levels of plasma carotenoids in 
HNSCC cases before and after radiotherapy were associated with improved progression-free 




believed to regulate epithelial cell differentiation through its effects on gene expression. 
Homo- and heterodimer complexes produced during metabolism of vitamin A bind to 
retinoic acid response elements (RARE) in promoter regions of specific genes, resulting in 
modification of cellular processes important in controlling carcinogenesis such as apoptosis 
(128, 129). Furthermore, retinoic acid and β-carotene may play a role in preventing 
uncontrolled cell growth by preserving gap junction communication between cells (129-131). 
β-carotene also functions as an antioxidant, quenching singlet oxygen species and scavenging 
peroxyl radicals, thus helping to prevent cellular damage (132).  
Recent findings of our research group show that HPV-positive cases may have 
enhanced adaptive immunity, which is associated with improved tumor response to 
chemotherapy and prolonged survival when compared to HPV-negative cases (133). Vitamin 
A, iron, and folate each play mechanistic roles in immune function. Vitamin A is necessary 
for both adaptive and innate immunity, and is involved in the anti-inflammatory response of 
T-helper cell 2 (Th2). A state of vitamin A deficiency is associated with reduced natural 
killer (NK) cell activity and antigen-specific response by Th1 cells (134). Differentiation and 
proliferation of NK and Th cells are modulated by cellular iron and therefore do not 
proliferate as rapidly under a state of iron deficiency (134). Folate works synergistically with 
vitamins B6 and B12 to supply one-carbon units during synthesis of nucleotides and proteins. 
A deficiency consequently results in decreased proliferation and number of circulating 
lymphocytes. Deficiency also is associated with an increased CD4+/CD8+ ratio (134). 
Associations between intake of vitamin A, folate, iron and immune function in HNSCC cases 




key role in the improved immune function and prognosis of individuals with HPV-positive 
tumors.  
While there was no significant difference between HPV-positive and HPV-negative 
cases reporting “ever” vs. “never” smoking, there was a marginally significant difference 
between the two groups when comparing current smoking and pack-years of overall 
exposure.  This suggests that although the same proportion of HPV-positive cases as HPV-
negative cases have smoked at some point in their lives, HPV-positive cases were more 
likely to have quit smoking and thus have less lifelong exposure to tobacco. While 
speculative, it also could indicate that smoking at an earlier age concurrent with HPV 
infection is associated with development of HNSCC. We did not have the statistical power to 
detect an interaction between diet and smoking, but this relationship should be examined in 
the future. 
Findings should be interpreted in light of several limitations. Although a common 
concern about HNSCC cases is inadequate micronutrient intake at the time of diagnosis, with 
the exception of vitamin E, vitamin D and calcium, at least 50% of our study population 
reported consuming adequate amounts of each micronutrient (based on Recommended Daily 
Allowances and Adequate Intake values) when considering intake from diet and 
supplements. However, reported intake may include some misclassification due to difficulty 
in recalling and quantifying foods consumed over the previous year. Our study does not 
include controls, preventing the ability to estimate risk of disease due to diet. Nevertheless, 
we note consistency with case-control studies of diet and HNSCC, where protective 




In conclusion, higher intakes of key micronutrients are associated with HPV-positive 
HNSCC. When consumed at higher levels these micronutrients and/or foods abundant in 
these micronutrients may increase the susceptibility of cases to HPV infection, or decrease 
the ability of the body to clear a persistent HPV infection. Also, it is possible that higher 
intakes of the micronutrients observed in this study to be associated with HPV-status play an 
independent role in the improved prognoses of HPV-positive HNSCC cases compared to 
HPV-negative cases. This hypothesis should be examined in the future, as it may present an 



































Table 3.1: Baseline characteristics by HPV status (n=143) 
Demographics Total HPV + HPV - p-value 
  Number (percent)   
N 143 38 (26.6) 105 (73.4) 
 Age (sd)† 57.9 57.89 (7.4) 57.88 (10.7) 0.99 
Sex†† 
           Male 115 34 (89.5) 81 (77.1) 0.10 
       Female 28 4 (10.5) 24 (22.9) 
 Race†† 
           White 133 37 (97.4) 96 (91.4) 0.38 
       Black 4 1 (2.6) 3 (2.9) 
        American Indian 6 0 (0) 6 (5.7) 
 Highest Education†† 
           ≤High School/GED 70 19 (50) 51 (48.5) 0.88 
       Some College 73 19 (50) 54 (51.4) 
 BMI in kg/m2 (sd)† 26.5 (5.8) 27.9 (4.6) 26.0 (6.1) 0.08 
Smoking†† 
           Current 44 7 (18.4) 37 (35.2) 0.15 
       Former 66 21 (55.3) 45 (42.9) 
        Never 33 10 (26.3) 23 (21.9) 
 Pack Years (median = 30)†† 
           ≥Median 59 11 (28.9) 48 (45.7) 0.07 
       <Median 84 27 (71.1) 57 (54.3) 
 Alcohol Problem†† 
            Yes 45 7 (18.4) 38 (36.2) 0.04* 
        No 98 31 (81.6) 67 (63.8) 
 Site†† 
           Oral Cavity 35 1 (2.6) 34 (32.4) <0.01* 
       Pharynx 108 37 (97.4) 71 (67.6) 
 Stage‡ 
           1, 2 16 1 (2.6) 15 (14.3) 0.17 
aaaa3 32 9 (23.7) 23 (21.9) 
 aaaa4 95 28 (73.7) 67 (63.8) 
 *Indicates significance at P<0.05 
† Student's t-test 
    †† Chi-square test or Fisher's exact test was used as appropriate 
 ‡ Wilcoxon rank-sum test 
 






Table 3.2: Quartile designations of nutrient intake among HNSCC patients (N = 143) 
  
Food and Supplements 
Percentile   Food Percentile 
Nutrient  25 50 75   25 50 75 
Vitamin A (IU/day)  5406 8589 12602 
 
3957 6074 8984 
Vitamin C (mg/day)  81.4 147 263 
 
57.1 97.4 155 
Vitamin E (mg/day)  6.6 13.4 27.3 
 
4.9 6.9 10.0 
β-carotene (μg/day)  1512 2484 4342 
 
1296 2127 3621 
Vitamin D (IU/day)  159 345 566 
 
101 171 256 
Calcium (mg/day)  620 914 1351 
 
538 770 1117 
Iron (mg/day)  10.7 15.9 24.1 
 
9.8 13.6 18.8 
Zinc (mg/day)  9.3 13.9 23.1 
 
8.6 11.7 16.2 
Copper (μg/day)  1.1 1.8 3.2 
 
1.1 1.5 2.0 
Riboflavin (mg/day)  2.2 3.2 4.5 
 
1.7 2.4 3.1 
Vitamin B12 (μg/day)  6.4 10.7 17.9 
 
4.7 7.0 10.1 
Folic acid (μg/day)  381 587 817 
 





Table 3.3: Adjusted odds of HPV+ status categorized by quartiles of total nutrient intake 
among oral and pharyngeal HNSCC patients (n=143)† 




     Quartile 2 11.18 (1.88 – 66.32) 0.003*    Quartile 2 4.30 (0.97 – 19.02) 0.003*
   Quartile 3 5.72 (1.00 – 33.00) 
 
   Quartile 3 1.86 (0.39 – 8.93) 
    Quartile 4 22.41 (3.57 – 140.84) 
 
   Quartile 4 14.45 (3.04 – 68.73) 
 Vitamin C 
  
Zinc 
     Quartile 2 4.09 (1.02 – 16.35) 0.261    Quartile 2 1.99 (0.56 – 7.14) 0.107 
   Quartile 3 3.38 (0.80 – 14.24) 
 
   Quartile 3 1.34 (0.37 - 4.88) 
    Quartile 4 2.82 (0.66 – 12.13) 
 
   Quartile 4 3.17 (0.94 - 10.72) 
 Vitamin E 
  
Copper 
     Quartile 2 2.39 (0.65 – 8.73) 0.041*    Quartile 2 1.03 (0.30 - 3.62) 0.344 
   Quartile 3 3.33 (0.87 – 12.71) 
 
   Quartile 3 2.41 (0.71 – 8.18) 
    Quartile 4 3.84 (1.04 – 14.16) 
 




     Quartile 2 1.18 (0.25 – 5.53) 0.018*    Quartile 2 1.93 (0.55 – 6.81) 0.093 
   Quartile 3 5.89 (1.51 – 23.01) 
 
   Quartile 3 3.12 ( 0.81 – 12.05) 
    Quartile 4 3.86 (1.00 – 14.99) 
 
   Quartile 4 2.80 (0.79 – 9.89) 
 Vitamin D 
  
Vitamin B12 
     Quartile 2 0.52 (0.15 - 1.79) 0.501    Quartile 2 1.44 (0.44 – 4.67) 0.229 
   Quartile 3 1.67 (0.50 – 5.60) 
 
   Quartile 3 2.05 (0.56 – 7.56) 
    Quartile 4 1.15 (0.33 - 3.98) 
 




     Quartile 2 0.78 (0.23 – 2.64) 0.308    Quartile 2 6.07 (1.47 – 25.07) 0.015* 
   Quartile 3 0.61 (0.15 - 2.38) 
 
   Quartile 3 3.54 (0.89 – 14.09) 
    Quartile 4 2.09 (0.58 – 7.56) 
 
   Quartile 4 8.97 (1.95 – 41.19) 
 *Indicates test for trend significant at P<0.05 adjusting for age, sex, BMI, tumor site, energy intake, problem drinking and pack years 





CHAPTER 4  




Background: No studies to date have examined associations between dietary patterns, 
carotenoids, and vitamin E in relation to proinflammatory cytokine levels in head and neck 
squamous cell carcinoma (HNSCC).  
  
Objective: The primary aim of this study was to determine if pretreatment dietary patterns 
and reported dietary intake and serum levels of carotenoids and tocopherols are associated 
with pretreatment proinflammatory cytokine levels in HNSCC. The secondary aim of this 
study was to examine associations between proinflammatory levels and the presence of 
cachexia. 
 
Design: This was a cross-sectional study of 161 newly diagnosed HNSCC patients who 
completed food frequency questionnaires (FFQ) and health surveys prior to treatment. 
Pretreatment serum levels of the proinflammatory cytokines IL-6, TNF-α, and IFN-γ were 
measured with ELISA and serum carotenoid levels were measured with HPLC. Three dietary 
patterns were identified using principal component analysis: whole foods, western, and 
convenience foods dietary patterns. Multivariable logistic regression models were used to 
examine quartiles of factor scores for dietary patterns derived from FFQ reports and serum 




alcohol problem. Multivariable logistic regression models also were used to assess 
associations between cytokine levels and presence of cachexia defined as weight loss >5%, 
or a baseline BMI of <20 kg/m
2
 and weight loss >2% within the timeframe between the 
baseline and six-month health questionnaire.  
 
Results: Three dietary patterns were identified: a whole foods pattern, Western pattern, and 
convenience foods pattern. In multivariable analyses, higher whole foods dietary pattern 
scores were significantly associated with lower levels of IL-6, TNF-α, and IFN-γ (P = 
<0.001, P = 0.008, and P = 0.03, respectively). Significant downward trends in IL-6, TNF-α, 
and IFN-γ levels were found across increasing quartiles of total reported carotenoid intake (P 
= 0.006, P = 0.04, and P = 0.04, respectively).  No significant association was reported for 
the relationships between IL-6 and TNF-α levels and serum carotenoids. There was a 
significant trend towards decreased IFN-γ levels across increasing quartiles of serum α-
tocopherol levels (P = 0.03). No significant association was observed between cytokine 
levels and cachexia.  
 
Conclusions: Consuming a diet rich in vegetables, fruit, fish, poultry and whole grains and 
higher intake of total carotenoids prior to diagnosis with HNSCC may be associated with 












Decreased risk of HNSCC recurrence and mortality has been related to higher fruit 
and vegetable intake (5, 48) and higher levels of serum carotenoids (68, 69). In a study of 
dietary patterns and HNSCC prognosis, we reported that higher pretreatment whole foods 
dietary pattern score, characterized by high intakes of vegetables, fruits, whole grains, 
poultry, and fish, and a BMI ≥ 25 kg/m
2 
at the time of diagnosis, are associated with lower 
recurrence and mortality rates (135). These findings suggest diet as a potential area of 
intervention to improve HNSCC prognosis. However, research exploring the potential 
mechanisms underlying the associations between diet and HNSCC disease outcomes is 
warranted to further understand how nutritional interventions can influence patient survival.  
Although inflammation is a protective biologic response by the body to destroy 
harmful stimuli, it is widely accepted that the inflammatory response also can be a major 
driver of cancer development and progression (136). The proinflammatory cytokines 
interleukin (IL)-6 and tumor necrosis factor (TNF)-α are both mediators of the immune 
response and are thought to be involved in malignant transformation, progression, and 
prognosis (136, 137). Endothelial cells in the tumor microenvironment, and HNSCC cells 
themselves, have been shown to secrete high levels of IL-6, inducing tumor invasion and 
metastasis (138, 139), possibly through regulation of cancer stem cells (140, 141). In 
epidemiologic studies, IL-6 has been correlated to later cancer stage (142-145) and poorer 
prognosis of several cancers (139, 143, 144, 146). Specifically, previous studies have 
reported high levels of IL-6 (147-149) and TNF-α (150) to be associated with increased 




important biomarker in predicting recurrence and mortality in a large, prospective cohort of 
HNSCC cases (91). 
Cancer cachexia, a wasting syndrome characterized by progressive skeletal muscle 
loss (with or without fat loss), functional impairment, and anorexia, is estimated to be present 
in approximately 48% - 61% of all HNSCC patients and accounts for ~20% of all cancer 
related deaths (46). IL-6, TNF-α, and interferon (IFN)-γ are hypothesized to play critical 
roles in the maintenance of body mass during cancer and in the pathogenesis of cachexia 
(151). Animal studies have shown that, IL-6, TNF-α, and IFN-γ induce cachexia by 
increasing glucocorticoid production in the body and upregulating ubiquitin proteosome 
activity, leading to anorexia and increased proteolysis, respectively (47). However, further 
research is necessary that describes the association between these cytokines and cachexia in 
humans. 
A large cohort study previously conducted by our research group examining 
associations between health behaviors and pretreatment IL-6 levels among HNSCC cases 
reported significantly higher IL-6 levels among smokers and subjects with sleep disturbances 
(152). Dietary intake has long been known to play a role in the physiological response to 
inflammation, but is yet to be investigated in HNSCC (153). It is reasonable to hypothesize 
that nutrients with antioxidant and anti-inflammatory properties such as carotenoids and 
vitamin E can mitigate the effects of proinflammatory cytokines in the body, reducing the 
likelihood of metastasis and cachexia and prolonging survival. To our knowledge, the 
potential relationships between dietary factors and cytokines have not been studied in 
HNSCC. The primary aim of this study was to examine the associations of these dietary 




serum levels of proinflammatory cytokines (IL-6, TNF-α, and IFN-γ) in a cohort of newly 
diagnosed HNSCC cases. A secondary aim was to examine differences in cytokine levels 
between cachectic and non-cachectic subjects in a subset of the study population.  
 




This was a cross-sectional, case-only study of patients enrolled in the University of 
Michigan Head and Neck Cancer, Specialized Program of Research Excellence (UM HN-
SPORE).  For the primary study aim, dietary patterns and micronutrients, as reported from a 
food frequency questionnaire (FFQ) and as measured in serum, were the independent 
variables. The reported dietary variables included derived dietary patterns (whole foods, 
Western, convenience foods), carotenoids (α-carotene, β-carotene, lycopene, β-
cryptoxanthin, and lutein + zeaxanthin) and total vitamin E. Serum-derived biochemical 
nutrient measures included α-carotene, β-carotene, total lycopene, β-cryptoxanthin, lutein, 
zeaxanthin, α-tocopherol, and γ-tocopherol. Pro-inflammatory cytokine levels were the 
outcome variables. These included IL-6, TNF-α, IFN-γ, and VEGF. Control variables were 
age, sex, tumor site, cancer stage, smoking, problem drinking, and education.  For the 




Patients newly diagnosed with HNSCC were recruited to participate in this study as 




University of Michigan Health System (Ann Arbor, MI). Patients were recruited between 
January 2008 and November 2012. Out of 737 patients approached, 670 consented, yielding 
a response rate of 91%. Exclusion criteria included: 1) < 18 years of age; 2) pregnant; 3) non-
English speaking; 4) diagnosed as mentally unstable; or 5) a diagnosis of another non-upper 
aerodigestive tract cancer. Excluded were patients who did not complete a baseline food 
frequency questionnaire (FFQ) (n = 304), withdrew from the study (n = 24), had reported 
daily energy intake <200 or >5000 kilocalories (kcals) per day (n = 6), or did not have 
baseline serum available for use in this study (n = 175). The final sample size included 161 
newly diagnosed HNSCC patients.  
Procedures 
 
Participants completed a pretreatment, self-administered health questionnaire at 
baseline and six months that collected data on demographics, tobacco use, alcohol use, 
weight status, sleep, comorbidities, depression and quality of life. Dietary intake was 
collected from subjects prior to treatment using the 2007 self-administered, semi-quantitative 
Harvard FFQ (154). A medical record review was completed at baseline and annually for 
each study participant from which data on tumor site and stage, treatment modalities, 
recurrence status, and survival were collected. 
Peripheral blood samples (30 mL) were collected prior to beginning treatment using 
routine venipuncture technique. Sera were collected after centrifugation of blood and stored 
in 0.5 mL aliquots at -80 °C until testing. To ensure patient confidentiality and to blind 
laboratory personnel, all serum samples were immediately barcoded and assigned a 






Reported dietary intake 
 
The 2007 Harvard FFQ was designed to assess respondents’ usual dietary intake from 
food and supplements over the past year. The reproducibility and validity of the 131-item 
questionnaire has been reported previously (56, 58, 61).  The FFQ includes standard portion 
sizes for each item (e.g., 1 medium banana or 3 oz chicken) which allowed participants to 
choose their average frequency of consumption over the past year from a list of 1-9 choices 
ranging from “almost never” to “≥6 times per day”. Total energy and nutrient intake was 
estimated by summing intakes from each food based on the portion size, frequency of 
consumption, and nutrient content of each food. Daily food servings were estimated by 
summing the frequency weights of each food item based on reported daily frequencies of 
consumption (56). 
Serum carotenoids and tocopherols 
  
 
 Serum carotenoids and tocopherols were extracted and analyzed by high pressure 
liquid chromatography as previously described (155). Briefly, serum was mixed with an 
equal volume of ethanol containing butylated hydroxytoluene and extracted with hexane 
using Tocol as the internal standard. A YMC C30 reverse phase column (2X150 mm with 
a 2.0X20mm guard) was used to separate carotenoids and tocopherols using gradient  elution 
at 0.2 ml/min total flow on a Shimadzu LC-20AT HPLC system. Detection was at 450-472 
nm for carotenoids, and electrochemical detection was used for Tocol and tocopherols with a 
Coularray electrochemical detector set at 310, 390 and 470 mV. Samples were analyzed in 






 Cachexia was defined as weight loss >5%, or a baseline BMI of <20 kg/m
2
 and 
weight loss >2% within the timeframe between the baseline and six-month health 
questionnaire (156). Participants who did not fit either of these criteria were considered to be 
non-cachectic. Weight in pounds and height in inches were self-reported on the health 
surveys at baseline and six months.   
Covariates 
 
Sociodemographic variables were age, sex, level of education. Smoking data 
permitted analysis by “current-past-never” smoking and alcohol abuse was measured using 
the previously validated Alcohol Use Disorders Identification Test (AUDIT) (76). An 
AUDIT score ≥8 was considered problem drinking. Tumor site was recorded from operative 
notes and surgical pathology forms and categorized into three groups: 1) oral cavity, 2) 
pharynx and 3) larynx. In order to increase statistical power of stage-wise comparisons, 
cancer stage was categorized a priori into three groups, with Stages 1 and 2 collapsed, while 
Stage 3 and Stage 4 were considered separately. Highest educational level attained was 
dichotomized as “≤ high school diploma or equivalent” and “some college or more”.  
Serum proinflammatory cytokine levels 
 
Cytokine levels were determined using standard methodology established in our 
laboratories or alternatively in our Cancer Center Immune Monitoring Core using 
commercially available paired-antibody ELISA kits. Briefly, serum sample aliquots frozen at 
– 80 °C were thawed, then incubated, overnight @ 4
o
C in duplicate (25ul/well) on microtiter 




Since the microplate arrays for analysis accommodated 174 duplicate samples at a time, all 
samples were analyzed in one batch. Any unbound substances were washed away and boitin- 
linked polyclonal antibody specific for the cytokine was introduced. After incubation for 2 
hours at room temperature, the plates were washed and incubated with streptavidin-HRP for 
an additional hour. After a final wash, substrate solution was then added and color 
development stopped after 25 minutes at room temperature. A microplate reader was then 
used to determine colorimetric densities for each sample as calculated from a standard curve. 
The test sensitivity was determined per manufacturer guidelines. For quality control, multiple 
plasma aliquots from a single donor were prepared and one aliquot analyzed with each batch 
of samples. For all assays, frozen aliquots were stored for repetitive testing if necessary. 
Statistical analysis 
 
Descriptive statistics (means and frequencies) were generated for all demographic, 
epidemiologic and clinical variables. Dietary intake data was assessed for missing values and 
energy outliers using the Rosner method (56, 157). Food consumption data derived from the 
FFQ were classified a priori into 40 foods and food groups using methods similar to those 
described in previous studies of dietary patterns and disease (53, 79) and as we previously 
reported.  Pretreatment dietary patterns present in the study population were derived by 
principal component analysis (PCA) using the orthogonal rotation procedure. In establishing 
the number of factors to retain in the final analysis, eigenvalues (≥3.0), Scree test, percentage 
of variability explained and interpretability of factors were considered (80). Pattern factor 
scores were calculated for each study participant by summing reported intakes of the factor 
food variables weighted by factor loadings. Dietary pattern scores were categorized into 




Multivariable logistic regression models were used to assess the relationship between 
dietary variables and cytokine levels. The cytokine counts were categorized into two or three 
levels according to their observed empirical count distribution. IFN-γ and IL-6 were both 
categorized into three levels: zero level, non-zero low level and non-zero high level, where 
the medians of the non-zero values were used to separate the latter two levels. TNF-α was 
dichotomized into zero and non-zero levels, due to the high proportion of zero-values (64%). 
For the outcomes with three levels, ordinal logistic model with the proportional odds 
assumption was employed. For each outcome, known confounders included in final models 
were selected based on results from a stepwise model selection with the whole foods pattern 
as the main predictor. For all three cytokines, odds ratios (ORs) with 95% confidence 
intervals (CIs) were calculated to quantify the magnitude of association. Dietary pattern 
scores and carotenoid and tocopherol levels were categorized into quartiles for use in 
statistical models and a test for linear trend across quartiles was conducted. All final models 
for this primary aim were adjusted for age, sex, tumor site, cancer stage, smoking, and 
alcohol problem. Multivariable logistic regression models were used to quantify the 
relationship between cachexia and cytokine levels. Final models for this secondary aim were 
adjusted for age, sex, stage, and smoking. The SAS system Version 9.3 (SAS Institute Inc., 




Characteristics of the study population are displayed in Table 1. The mean age of 
study participants was approximately 60 years. The majority of participants were white 
(94.4%) and male (80.1%). About 60% of the participants had at least some college 




participants presented to UMHS clinics with late-stage (III or IV) cancers (84.9%). About 
74% of participants were ever smokers, with about one quarter reporting an alcohol problem 
(16.2% with AUDIT score ≥ 8). The mean BMI at the time of diagnosis was 27.2 kg/m
2
, 
which is considered overweight but lower than the average BMI of 28.7 kg/m
2 
in the United 
States population from 1999 – 2010 (158). Approximately 57% of the 122 participants who 
completed six month health questionnaires were classified as cachectic.  
Three major dietary patterns were identified with PCA. The first pattern, termed the 
“whole foods pattern”, was characterized by high intakes of vegetables, fruits, legumes, fish, 
poultry, fruit juice, water, and wine, and low intakes of sugar sweetened beverages and beer. 
The second pattern, termed the “Western pattern”, was characterized by high intakes of red 
and processed meats, refined grains, condiments, eggs, coffee, butter, and high-fat dairy, and 
low intakes of fruits, legumes and cereals. The third pattern, termed the “convenience foods 
pattern” was characterized by high intakes of cereals, pizza, desserts, diet beverages, and 
energy bars, and low intakes of other vegetables and beer. The factor-loading matrix for the 
three dietary patterns is presented in Table 2. 
There was a significant trend towards decreased IL-6, TNF-α, and IFN-γ levels across 
increasing quartiles of whole foods pattern score (P = <0.001, P = 0.008, and P = 0.03, 
respectively, Table 3). Significant trends toward decreased IL-6, TNF-α, and IFN-γ levels 
were also found across increasing quartiles of total carotenoid intake (P = 0.006, P = 0.04, 
and P = 0.04, respectively). Significant inverse associations across increasing quartiles of 
lycopene intake were observed for IL-6 (P = 0.03) and across increasing quartiles of total 




No significant associations were reported for the relationships between IL-6 and 
TNF-α levels and serum carotenoids (Table 4). There was a significant trend towards 
decreased IFN-γ levels across increasing quartiles of serum α-tocopherol and β-cryptoxanthin 
levels (P = 0.03 and P = 0.03, respectively). Results of multivariable logistic regression 
models examining the relationships between the IL-6, TNF-α, and IFN-γ and cachexia 
showed no statistically significant associations. The odds ratios and 95% CIs for these 
associations can be seen in Table 5.  
Discussion 
 
The most significant findings of this study were that high whole foods dietary pattern 
scores and reported intake of total carotenoids prior to treatment were associated with 
significantly lower serum proinflammatory cytokine levels of IL-6, TNF-α, and IFN-γ, 
independent of other factors known to modulate cytokine levels (152).  Additionally, higher 
reported intake of lycopene was significantly associated with lower IL-6 levels, and higher 
reported vitamin E intake and serum α-tocopherol levels were associated with lower IFN-γ 
levels. We did not find any significant associations between proinflammatory levels and 
presence of cachexia. 
To our knowledge, this is the first study to examine the relationship of dietary 
patterns and carotenoids with serum proinflammatory cytokine levels in HNSCC patients. 
Nevertheless, our results support the work of prior research examining this relationship in 
other study populations. In a prospective analysis conducted among a population of older 
adults as part of the Health, Aging, and Body Composition (Health ABC) Study, a ‘healthy’ 
dietary pattern, (consistent with our whole foods dietary pattern, high in low-fat dairy 




levels than a dietary pattern high in sweets and desserts and high-fat dairy products (159). An 
intervention trial conducted among males with metabolic syndrome reported that 
randomization to a Mediterranean diet, rich in foods characteristic of our whole foods dietary 
pattern, had significantly lower levels of IL-6 and TNF-α after five weeks in comparison to 
the control group (160). 
A cross-sectional study of healthy young adults enrolled into the Toronto 
Nutrigenomics and Health Study reported strong inverse correlations between biochemical 
levels of α-tocopherol levels and IFN-γ (161). Results of another study conducted in breast 
cancer cases indicated that low α-tocopherol plasma concentrations were associated with 
increased expression of the gene encoding IFN-γ expression (162). This results are consistent 
with our study of HNSCC subjects, in which we found high reported intake of total vitamin E 
as well as serum levels of α-tocopherol were associated with lower levels of IFN-γ. 
Although we reported a statistically significant inverse association between IL-6 
levels and biochemical measures of total carotenoids, a cross-sectional study conducted 
among patients diagnosed with advanced coronary artery disease reported an inverse 
relationship between IL-6 and plasma β-carotene levels (163). In agreement with the results 
of our study, higher serum concentrations of total carotenoids were found to be correlated 
with lower IL-6 and TNF-α levels in subjects with recent hip fractures (164). A significant 
inverse relationship also was found between IL-6 and TNF-α levels and serum α-tocopherol 
concentrations in the same study (164). In contrast, a case-control study of breast cancer risk 





A number of epidemiologic and clinical studies have implicated the NF-κB signaling 
pathway and NF-κB-mediated proinflammatory cytokines as drivers in the development of 
cancer-related symptoms, making this pathway a potential target for therapeutic intervention 
(166).  While IL-6 and TNF-α are both stimulated by NF-κB (166), macrophages stimulated 
with IFN-γ activate the NF-κB pathway (167). One mechanism by which the whole foods 
dietary pattern, carotenoids, and tocopherols may help to reduce circulating proinflammatory 
cytokine levels in HNSCC patients is through modulation of the NF-κB pathway. Oxidative 
stress has been reported to activate the NF-κB family of transcription factors, upregulating 
expression of proinflammatory cytokines (165, 168). Nutrients that can reduce oxidative 
stress and inflammation in the body such as carotenoids and tocopherols—nutrients found in 
abundance in foods that characterize the whole foods dietary pattern—have been identified to 
suppress NF-κB in laboratory studies (169).  
Despite findings from several animal studies suggesting roles of IL-6, TNF-α, and 
IFN-γ in the development of cancer cachexia, we did not find any differences in levels of 
these cytokines in cachectic versus non-cachectic HNSCC subjects. It is likely that our use of 
self-reported weight was not sufficient to make valid diagnoses of cachexia and led to 
misclassification. Evidence from prior studies suggests that classification of cachexia using 
measures of weight and BMI are challenging, particularly in overweight and obese patients 
(170). To substantiate the results of animal models of cachexia, future research is warranted 
that examines the role of proinflammatory cytokines in cachexia pathogenesis in which valid 
and objective measures of body composition are used, such as clinically measured BMI 
combined with skinfold measures, dual x-ray absorptiometry (DEXA) and computed 




Although we found several significant associations between reported dietary variables 
and proinflammatory cytokine levels, with the exception of α-tocopherol and beta-
cryptoxanthin with IFN-γ, we did not find any significant associations between cytokine 
levels and biochemical measures of carotenoids and tocopherols. This suggests that perhaps 
there are other dietary constituents driving the associations of reported carotenoid intake with 
cytokine levels that are highly correlated with carotenoids. These could include bioactive 
compounds found in fruits and vegetables such as polyphenolic compounds and flavonoids. 
Flavonoids have been shown to inhibit NF-κB signaling and downregulate the expression of 
proinflammatory markers and should be examined in relation to proinflammatory cytokines 
in HNSCC in the future (171). 
This study used comprehensive dietary and biochemical data collected from subjects 
and had the ability to adjust for multiple potential confounding factors which strengthened 
our conclusions. We were limited by the cross-sectional design, because this study design 
allowed for the determination of associations between diet and cytokines, but does not prove 
causation. We were also limited by the use of self-reported weight and height to define 
cachexia and the small sample size. As with any epidemiologic study involving self-reported 
recall of diet, measurement error leading to misclassification bias is likely to have occurred. 
However, this type of bias is likely to attenuate associations towards the null (56). Because 
patients reported their usual pre-diagnosis dietary intake after their cancer diagnosis, recall 
bias related to social desirability, stress of the diagnosis, or concerns about contributing to 
their own disease could have occurred. While recall bias is a concern, previous studies of diet 
and breast cancer indicate either little evidence of recall bias (98, 99), or that the measures of 




consisted predominantly of white males, the results may not be generalizable to racially 
diverse HNSCC populations. 
In summary, diet, particularly a whole foods dietary pattern and total carotenoid 
intake, appears to be associated with lower systemic inflammation in HNSCC cases, as 
measured by serum levels of IL-6, TNF-α, and IFN-γ. The ability of carotenoids and other 
dietary compounds found in foods characterizing the whole foods pattern to decrease levels 
of proinflammatory cytokines may provide mechanistic evidence for our previous described 
findings of the association between the whole foods dietary pattern and prolonged survival. 
In addition to targeting inflammation, it is well accepted that carotenoids and other dietary 
compounds consistent with the whole foods dietary pattern target other cancer-related 
mechanisms such as oxidative stress, cell growth, proliferation and apoptosis, angiogenesis, 
phase II detoxification enzymes, and epigenetic regulation of tumor suppressor genes (82-
84). Given its multifaceted properties, along with the low-cost, feasibility, and non-invasive 
nature of implementing interventions, diet is a particularly attractive target for improving 
HNSCC progression, symptoms, and outcomes.  
The results of this study can serve as the basis for translational intervention research 
in HNSCC populations, where the aim is to increase the consumption of foods characteristic 
of the whole foods dietary pattern, with particular focus on foods abundant in carotenoids 
such as green leafy vegetables, orange and yellow fruits and vegetables, and tomatoes. 
Before the most optimal dietary interventions can be developed and implemented, further 
research is necessary that is attentive to the unique challenges of the HNSCC population, 




food security, social support, and chewing and swallowing problems related to the course and 










Table 4.1: Pretreatment Characteristics of Newly Diagnosed 
Head and Neck Cancer Patients 
Characteristic No. of Patients (n = 161) % 
Age, years   
     Mean 59.7  
     SD 10.7  
     Range 25 - 93  
Sex   
     Male 129 80.1 
     Female 32 19.9 
Race   
    White/Non-Hispanic 152 94.4 
     Non-white/Hispanic 9 5.6 
Education   
     High School or Less 63 39.1 
     Some College or More 98 60.9 
Site   
     Oral Cavity 49 30.4 
     Oropharynx 77 47.8 
     Larynx 35 21.7 
Stage   
     1,2 25 15.5 
iiii3 24 14.9 
iiii4 112 69.6 
Smoking   
     Current 25 15.5 
     Former 94 58.4 
     Never 42 26.1 
Alcohol Problem (AUDIT ≥8)  
     Yes 26 16.2 
     No 135 83.8 
Cachexia   
    Cachectic 69 56.6 
    Non-cachectic 53 43.4 
BMI (kg/m
2
)   
     Mean 27.2  
     SD 5.5  
     Range 13.1 – 54.4  
 
 










Table 4.2. Factor loading matrix for three dietary patterns (n=161) 
Food Group Whole Foods Western 
Convenience 
Foods 
Dark Yellow Vegetables 0.75 *** *** 
Green Leafy 0.72 *** *** 
Cruciferous 0.66 *** *** 
Tomatoes 0.65 *** *** 
Fruit 0.54 -0.35 *** 
Poultry 0.50 *** *** 
Legumes 0.50 -0.32 *** 
Fish 0.47 *** *** 
Other Vegetables 0.44 *** -0.31 
Juice 0.40 *** *** 
Wine 0.31 *** *** 
Water 0.31 *** *** 
Whole grains *** *** *** 
Mayonaisse *** *** *** 
Low-fat dairy *** *** *** 
Unsaturated fats *** *** *** 
Margarine *** *** *** 
Sugar sweetened beverages -0.40 *** *** 
Beer -0.42 *** -0.40 
Red Meats *** 0.59 *** 
Processed meats *** 0.54 *** 
Refined grains *** 0.40 *** 
Condiments *** 0.43 *** 
Eggs *** 0.45 *** 
Coffee *** 0.36 *** 
Butter *** 0.38 *** 
High-fat dairy *** *** *** 
Liquor *** *** *** 
Organ meats *** *** *** 
Teas *** *** *** 
Cereals *** -0.36 0.62 
Pizza *** *** 0.51 
Desserts *** *** 0.47 
Diet beverages *** *** 0.50 
Energy bars *** *** 0.40 
French fries *** *** *** 
Artificial sweeteners *** *** *** 
Snacks *** *** *** 
Potatoes *** *** *** 





Table 4.3: Multivariable† odds ratios and 95% confidence intervals for proinflammatory 
cytokine levels by quartile (Q) of FFQ reported dietary patterns and nutrient intake‡ (n=161) 
 
IL-6 
  Q2 Q3 Q4 Ptrend 
Whole foods pattern 0.41 (0.16, 1.04) 0.32 (0.12, 0.86) 0.16 (0.06, 0.45) <0.001* 
Western pattern 1.19 (0.49, 2.87) 0.48 (0.19, 1.22) 0.70 (0.27, 1.77) 0.20 
Convenience foods pattern 0.90 (0.36, 2.23) 1.19 (0.49, 2.90) 0.80 (0.32, 1.98) 0.80 
Total vitamin E (μg/day) 0.81 (0.32, 2.01) 0.90 (0.36, 2.26) 0.54 (0.22, 1.34) 0.23 
α-carotene (μg/day) 0.48 (0.20, 1.18) 0.49 (0.19, 1.24) 0.61 (0.24, 1.60) 0.33 
β-carotene (μg/day) 0.57 (0.23, 1.42) 0.55 (0.21, 1.43) 0.59 (0.22, 1.59) 0.31 
Lycopene (μg/day) 1.01 (0.39, 2.58) 1.09 (0.40, 2.97) 0.35 (0.13, 0.94) 0.03* 
β-cryptoxanthin (μg/day) 0.30 (0.11, 0.81) 0.64 (0.25, 1.63) 0.40 (0.15, 1.04) 0.27 
Lutein + zeaxanthin (μg/day) 0.67 (0.28, 1.64) 0.57 (0.23, 1.43) 0.45 (0.17, 1.20) 0.11 
Total carotenoids (μg/day) 0.42 (0.17, 1.06) 0.59 (0.23, 1.53) 0.19 (0.23, 1.53) 0.006* 
  TNF-α 
  Q2 Q3 Q4 Ptrend 
Whole foods pattern 0.41 (0.14, 1.18) 0.29 (0.09, 0.92) 0.19 (0.06, 0.64) 0.008* 
Western pattern 0.91 (0.34, 2.45) 0.62 (0.21, 1.81) 0.63 (0.21, 1.83) 0.31 
Convenience foods pattern 1.21 (0.43, 3.43) 1.18 (0.42, 3.25) 0.44 (0.14, 1.33) 0.16 
Total vitamin E (μg/day) 0.92 (0.32, 2.63) 1.09 (0.38, 3.14) 0.76 (0.27, 2.16) 0.69 
α-carotene (μg/day) 0.42 (0.15, 1.22) 0.60 (0.21, 1.72) 0.72 (0.25, 2.10) 0.67 
β-carotene (μg/day) 0.36 (0.12, 1.05) 0.30 (0.10, 0.95) 0.60 (0.20, 1.83) 0.44 
Lycopene (μg/day) 0.45 (0.15, 1.37) 0.99 (0.32, 3.11) 0.24 (0.07, 0.84) 0.08 
β-cryptoxanthin (μg/day) 0.52 (0.17, 1.59) 0.61 (0.21, 1.77) 0.69 (0.24, 2.02) 0.67 
Lutein + zeaxanthin (μg/day) 0.48 (0.17, 1.36) 0.68 (0.25, 1.90) 0.31 (0.10, 0.99) 0.09 
Total carotenoids (μg/day) 0.38 (0.13, 1.09) 0.64 (0.22, 1.88) 0.22 (0.07, 0.72) 0.04* 
  IFN-γ 
  Q2 Q3 Q4 Ptrend 
Whole foods pattern 0.58 (0.23, 1.48) 0.40 (0.15, 1.10) 0.32 (0.12, 0.90) 0.03* 
Western pattern 0.90 (0.37, 2.17) 0.75 (0.29, 1.92) 1.33 (0.52, 3.42) 0.64 
Convenience foods pattern 1.34 (0.53, 3.36) 1.59 (0.64, 3.94) 0.84 (0.34, 2.12) 0.79 
Total vitamin E (μg/day) 0.53 (0.21, 1.36) 0.32 (0.12, 0.84) 0.27 (0.10, 0.70) 0.004* 
α-carotene (μg/day) 0.76 (0.31, 1.88) 0.79 (0.31, 2.01) 0.79 (0.31, 2.07) 0.67 
β-carotene (μg/day) 0.87 (0.35, 2.20) 0.46 (0.17, 1.23) 0.61 (0.22, 1.65) 0.21 
Lycopene (μg/day) 0.85 (0.33, 2.21) 1.17 (0.43, 3.21) 0.60 (0.22, 1.62) 0.38 
β-cryptoxanthin (μg/day) 0.16 (0.06, 0.47) 0.51 (0.20, 1.35) 0.27 (0.10, 1.35) 0.14 
Lutein + zeaxanthin (μg/day) 1.08 (0.44, 2.68) 0.58 (0.23, 1.47) 0.56 (0.21, 1.49) 0.14 
Total carotenoids (μg/day) 0.45 (0.18, 1.16) 0.69 (0.26, 1.81) 0.29 (0.10, 0.78) 0.04* 
†Adjusted for age, sex, tumor site, cancer stage, smoking, and alcohol problem 
‡Odds ratios are comparing each of the upper quartiles to the lowest quartile 1 





Table 4.4: Multivariable† odds ratios and 95% confidence intervals for proinflammatory 
cytokine levels by quartile (Q) of nutrient biomarker levels‡ (n=151) 
  IL-6 
  Q2 Q3 Q4 Ptrend 
Biomarker (μg/ml)   
   α-tocopherol  0.80 (0.33, 1.93) 1.07 (0.44, 2.64) 1.21 (0.49, 2.98) 0.56 
γ-tocopherol 1.80 (0.74, 4.37) 0.92 (0.38, 2.21) 1.23 (0.51, 2.96) 0.97 
α-carotene 0.84 (0.34, 2.05) 0.97 (0.38, 2.48) 0.97 (0.36, 2.59) 0.98 
β-carotene 0.87 (0.35, 2.15) 1.48 (0.58, 3.75) 1.25 (0.50, 3.15) 0.43 
Lycopene 1.02 (0.42, 2.48) 0.64 (0.26, 1.59) 0.78 (0.30, 1.99) 0.43 
β-cryptoxanthin 0.30 (0.11, 0.81) 0.64 (0.25, 1.63) 0.40 (0.15, 1.04) 0.27 
Lutein 0.83 (0.34, 2.02) 0.52 (0.20, 1.35) 0.97 (0.38, 2.52) 0.73 
Zeaxanthin 0.81 (0.33, 1.97) 0.77 (0.31, 1.91) 0.60 (0.23, 1.52) 0.29 
Total carotenoids 0.63 (0.26, 1.55) 1.15 (0.45, 2.93) 0.71 (0.27, 1.81) 0.70 
  TNF-α 
 
Q2 Q3 Q4 Ptrend 
Biomarker (μg/ml)   
   α-tocopherol 1.39 (0.47, 4.06) 2.70 (0.90, 8.10) 1.92 (0.65, 5.69) 0.28 
γ-tocopherol 1.98 (0.61, 6.41) 2.10 (0.68, 6.50) 1.85 (0.57, 6.03) 0.33 
α-carotene 2.54 (0.73, 8.89) 2.44 (0.71, 8.33) 1.51 (0.44, 5.19) 0.57 
β-carotene 2.45 (0.75, 8.02) 3.31 (0.91, 12.06) 1.02 (0.26, 3.99) 0.96 
Lycopene 1.28 (0.42, 3.88) 0.88 (0.27, 2.86) 1.35 (0.41, 4.45) 0.72 
β-cryptoxanthin 2.25 (0.70, 7.28) 1.39 (0.44, 4.37) 1.18 (0.34, 4.06) 0.92 
Lutein 1.73 (0.54, 5.53) 2.33 (0.68, 7.97) 2.35 (0.71, 7.80) 0.16 
Zeaxanthin 1.14 (0.35, 3.71) 2.31 (0.76, 6.97) 0.80 (0.23, 2.77) 0.88 
Total carotenoids 0.79 (0.26, 2.41) 1.21 (0.38, 3.87) 0.87 (0.26, 2.91) 0.93 
  IFN-γ 
  Q2 Q3 Q4 Ptrend 
Biomarker (μg/ml)   
   α-tocopherol 0.99 (0.41, 2.42) 0.90 (0.35, 2.26) 0.62 (0.25, 1.57) 0.03* 
γ-tocopherol 2.68 (0.99, 7.27) 1.61 (0.62, 4.22) 1.39 (0.51, 3.78) 0.90 
α-carotene 1.51 (0.54, 4.27) 1.51 (0.54, 4.21) 1.20 (0.42, 3.40) 0.76 
β-carotene 0.88 (0.34, 2.32) 1.62 (0.55, 4.76) 0.91 (0.30, 2.78) 0.91 
Lycopene 0.98 (0.38, 2.53) 0.60 (0.22, 1.68) 1.25 (0.44, 3.52) 0.82 
β-cryptoxanthin 0.94 (0.35, 2.48) 0.60 (0.23, 1.57) 0.35 (0.12, 1.01) 0.03* 
Lutein 1.07 (0.42, 2.73) 0.94 (0.34, 2.64) 0.73 (0.27, 1.99) 0.51 
Zeaxanthin 0.68 (0.26, 1.79) 0.72 (0.28, 1.85) 0.42 (0.15, 1.20) 0.14 
Total carotenoids 0.76 (0.30, 1.95) 0.61 (0.22, 1.66) 0.53 (0.18, 1.54) 0.23 
†Adjusted for age, sex, tumor site, cancer stage, smoking, and alcohol problem 
  ‡Odds ratios are comparing each of the upper quartiles to the lowest quartile 1 






Table 4.5: Multivariable† odds ratios and 95% confidence 
intervals for cachexia‡ by proinflammatory levels (n=122) 
Cytokine OR (95% CI) P-value 
IL-6 
      Below median vs. zero 1.23 (0.47, 3.19) 0.90 
    Above median vs. zero 1.35 (0.54, 3.35) 0.64 
TNF-α 
      Non-zero vs. zero 1.55 (0.69, 3.45) 0.29 
IFN-γ 
      Below median vs. zero 0.99 (0.40, 2.52) 0.82 
    Above median vs. zero 0.82 (0.32, 2.12) 0.66 
†Adjusted for age, sex, tumor site, cancer stage, and smoking 
‡Cachexia was defined as weight loss >5%, or a baseline BMI of <20 kg/m2 and weight loss >2% within the timeframe between the 









This purpose of this dissertation research was to investigate the role of diet in 
HNSCC progression and prognosis. The objective of Chapter 2 was to examine how diet and 
weight status are associated with HNSCC prognosis. Chapter 3 aimed to describe differences 
in micronutrient intake of HNSCC cases by HPV-status of the tumor. The objective of 
Chapter 4 was to investigate associations between pretreatment proinflammatory cytokine 
levels with dietary patterns, carotenoids, and presence of cachexia. This research provided 
insight into how diet can influence HNSCC prognosis, how diets of HNSCC cases differ 
according to disease subtype, providing one hypothesis for the discrepancy in survival rates 
between the two groups, and, finally, a potential molecular mechanism by which diet may 
exert its effects on HNSCC progression and survival. 
In Chapter 2 we established that following a more healthful, pretreatment, “whole 
foods” dietary pattern, as well as being overweight or obese at the time of HNSCC diagnosis 
is associated with lower recurrence and mortality rates. This was the largest study to date 
investigating the role of diet in HNSCC recurrence and mortality, and the first to describe the 
association of HNSCC outcomes with overall diet (i.e. dietary patterns) as opposed to 
individual foods and nutrients. These findings have important implications for clinical 
practice, suggesting that patients may benefit from nutritional intervention early in the 
disease trajectory. More aggressive surveillance may be advantageous in patients presenting 




term follow-up time and large sample size were strengths of this analysis. Limitations of this 
research include the observational study design, as it allowed for the determination of an 
association, but not the determination of causation, the heterogeneous nature of the study 
population, the potential for recall and misclassification bias of diet, and the lack of statistical 
power to consider HPV-status of the tumor as a potential confounding or effect modifying 
factor.  
In Chapter 3 we reported higher intake of key micronutrients with anti-cancer and 
anti-metastatic properties in HPV-positive HNSCC cases compared to HPV-negative. 
Although several previous studies have reported differences in epidemiologic characteristics 
between HPV-positive and HPV-negative HNSCC cases, this is the first to document 
differences in dietary intake between the two groups. The micronutrients reported to be 
consumed in greater quantity by HPV-positive subjects compared to HPV-negative—folate, 
iron, β-carotene, vitamin E, and vitamin A—are abundant nutrients found in many of the 
foods that characterize the whole foods dietary pattern that was associated with survival in 
Chapter 2. These results are important because they provide support for the hypothesis that 
diet may be one factor contributing to the lower survival rates observed among HPV-
negative HNSCC cases and this hypothesis should be investigated more thoroughly in the 
future. Limitations of this analysis include the small sample size, cross-sectional design as it 
raises the question of temporal ambiguity, and the lack of statistical power to test for 
potential interactions between diet and smoking status. Nevertheless, based on these results, 
it may be beneficial to develop interventions targeted at HPV-negative HNSCC cases that 




Chapter 4 provided a possible molecular basis for the relationship between higher 
whole foods dietary pattern score and improved HNSCC survival, establishing an association 
of higher pretreatment whole foods dietary pattern score and carotenoid intake with lower 
pretreatment levels of the proinflammatory cytokines IL-6, TNF-α, and IFN-γ.  These 
cytokines have previously been linked to tumor invasion and metastasis (138, 139), higher 
cancer stage (142-145), cancer cachexia (46), and poorer prognosis of HNSCC (147-150). 
These findings are particularly interesting in light of the conclusion that higher IL-6 
significantly predicted recurrence and mortality in a previous study of a University of 
Michigan Head and Neck SPORE cohort (91).  
To our knowledge, this was the first study to investigate associations between diet 
and proinflammatory cytokines in an HNSCC population. We did not find significant 
associations between pretreatment proinflammatory levels and presence of cachexia, 
although these associations have been well established in animal models. More rigorous 
studies of the role proinflammatory cytokines play in the regulation of lean body mass and 
appetite in human cancer cases should be conducted in the future. These studies should 
include more comprehensive measures of body mass, using methods such as DEXA and CT 
scans, as well as longitudinal measures of cytokines and hormones involved in appetite 
regulation, such as ghrelin, leptin, and neuropeptide Y (NPY), and finally, the influence 
physical activity may have on these associations.  
Although not part of this dissertation, prior work of our group reported an association 
between diet and tumor DNA methylation status of tumor suppressor genes in HNSCC. 
Specifically, we showed that higher intakes of folate, vitamin B12, vitamin A, and 




individual CpG sites across 237 genes on the Goldengate Cancer Panel linked to tumor 
suppression (84). Many of the foods that characterize the whole foods dietary pattern are rich 
sources of folate, vitamin B12, and vitamin A, and cruciferous vegetables loaded highly on 
this pattern. This suggests that enhanced expression of tumor suppressor genes via decreased 
DNA methylation is another possible mechanism underlying the epidemiologic association 
between the whole foods dietary pattern and survival described in Chapter 2.  
Longitudinal studies of dietary consumption patterns in HNSCC patients and how 
these patterns change throughout the disease course and after remission are warranted.  
Associations between change in dietary patterns over time with recurrence, long-term 
survival, and development of second primary cancers should also be investigated. 
Understanding how diet, in general, and changes in diet after HNSCC diagnosis are 
associated with variations in demographic, behavioral, environmental, and genetic 
characteristics would be beneficial in developing individualized interventions that target 
those patients at high-risk for poor diet. Such interventions should be implemented early in 
the disease trajectory to optimize the likelihood of favorable disease outcomes.  
More broadly, the results of this dissertation research would likely be safe to translate 
to clinical practice immediately, where treating clinicians can recommend the consumption 
of higher intake of vegetables, fruits, legumes, fish, poultry, whole-grains, fruit juice, olive 
oil, nuts and garlic to their HNSCC patients. Intervention studies should be conducted in the 
future aimed at increasing intake of these foods in HNSCC patients and qualitative or mixed 
methods studies should also be conducted in which barriers to consumption of these foods 




difficulties. Future research should also focus on the development and delivery of nutrition 
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